HerzzentrumUniversitŠtsspital Basel

Herzzentrum

HerzzentrumJahresbericht 2017

02

Mehr wissen. Alles geben.Mehr machen. Besser kšnnen.Zusammen arbeiten. Mehr erreichen.

03

Vorwort

Liebe Kolleginnen und Kollegen, liebe Leserinnen und Leser

In Zeiten eines immer schnelleren Umbruchs stehen wir im Herzzentrum des Univer-sitŠtsspitals Basel fŸr BestŠndigkeit und QualitŠt in Therapie, Innovation und Forschung. Gerade in der Behandlung von Herzerkrankungen eršffnen sich faszinierende und neue Therapiemšglichkeiten zum Nutzen unserer Patienten und Patientinnen. Parallel dazu steigen aber auch der permanente Druck auf Kosten und Prozessoptimierun-gen. Somit spielt auch der betriebswirtschaftliche Aspekt eine immer bedeutendere Rolle. In diesem Spannungsfeld arbeiten alle Teams des Herzzentrums tagtŠglich fŸr die kontinuierliche Verbesserung von BehandlungsqualitŠt und Serviceleistung.

Alle Spitzenleistungen unseres Herzzentrums sind nur durch die enge Verzahnung mit Ihnen als HausŠrzt(inn)en und niedergelassenen Kardiolog(inn)en mšglich. Der enge fachliche und persšnliche Austausch mit Ihnen bildet dabei die Basis fŸr die BehandlungskontinuitŠt und den Langzeiterfolg.

Herzlichen Dank fŸr Ihren offenen Dialog und konstruktives Feedback sowie fŸr die sehr gute Zusammenarbeit.

Friedrich Eckstein Christian MŸller Stefan Osswald

04

Inhalt

01 Dienstleistungen 06 - 13

Leistungsstatistik UniversitŠtsspital Kardiologie / Herzchirurgie / PartnerspitŠler Outcomestatistik 02 Kardiologie 14 - 25

Interventionelle Kardiologie Elektrophysiologie Echokardiographie Cardiac Imaging Herzinsuffizienz KardiovaskulŠre PrŠvention / GUCH KARAMBA (Kardiale Rehabilitation) Kurzzeitklinik / Pflege / MTT / MTRA Administration / Controlling Outcome Forschung Swiss-AF Cohort Study Grundlagenforschung 03 Herzchirurgie 26 - 29

04 Notfallzentrum 30 - 31

05 Medizinische Intensivstation 32 - 33

06 KardioanŠsthesie 34 - 35 07 Operative Intensivbehandlung (OIB) 36 - 37

08 Lehre 38 - 39

09 Finanzielles 40 - 43 10 Publikationen Kardiologie / Herzchirurgie 44 - 55

Originalarbeiten / Reviews / Editorials / Letters to the editor Case reports / Books & Book chapters

11 Auszeichnungen 56 - 57

12 Kontakt 58

05

StationŠre Patienten

Kardiologische Ambulatorien

Schrittmacherkontrollen

ICD-Kontrollen

Rhythmussprechstunde

Kardiologische AbklŠrungen

Herzinsuffizienz-Sprechstunde

LVAD-Kontrollen

GUCH-Sprechstunde

Privatsprechstunden

Hypertonie Sprechstunde

Rauchstopp Sprechstunde

Konsile

Spezialuntersuchungen

Linksherzkatheter

Rechtsherzkatheter

Myokard-Biopsie

Elektrophysiologische Untersuchungen

Echokardiographien, transthorakal

Echokardiographien, transoesophageal

Stressechokardiographien

24 h Blutdruckmessungen

Somnotouch

Herz-MR

Herz-CT

Ergometrien (inkl. Nuklearmedizin)

Spiroergometrien

Myokardperfusionsszintigraphien

Herz-PET

2017

2'191

1'712

1'582

481

1'463

587

86

140

1'451

1'277

968

2'520

2'481

156

15

82

11'691

1'118

236

1'275

471

994

586

2'301

120

977

685

2015

2'050

1'644

1'514

398

881

547

n.a.

122

1008

813

541

1'459

2'525

175

23

80

9'275

979

145

1004

137

715

232

1'248

72

1'618

n.a.

Leistungsstatistik Kardiologie UniversitŠtsspital

Dienstleistungen

01 Dienstleistungen

06

2014

1'872

1'704

1'757

403

678

460

n.a.

123

846

730

497

2'002

2'354

179

25

53

8'854

891

123

846

n.a.

627

277

1'195

83

1'571

n.a.

2016

2'200

1'691

1'649

452

1'049

547

45

130

1'304

1'001

758

1'602

2'473

155

27

71

10'810

1'051

220

1'224

296

738

356

2'074

84

1'466

55

Elektrokardiographie

Ruhe-EKG 1

Langzeit-EKG Untersuchungen inkl. R-Tests

Therapie

Kardioversionen

Schrittmacherimplantationen

Schrittmacherwechsel / Schrittmacherrevision

Elektrodenentfernungen

ICD-Implantationen

ICD-Wechsel / ICD-Revision

CRT-ICD / CRT-PM

Implantierbare Loop Recorder

Ablationen

PTCA

Mehrast-PTCA

Sinus Coronarius Reduktion

Aortenvalvuloplastien

Verschluss eines ASD / PFO

Nicht operativer Aortenklappenersatz (TAVI)

- davon transfemoral

- davon transapikal

MitraClip

Indirekte Mitralklappenanuloplastie

Direkte Mitralklappenanuloplastie

Renale Denervationen

Vorhofsohrverschluss

Mitralklappenvalvuloplastien

ParavalvulŠrer Leckverschluss

TASH

Rehabilitation (KARAMBA)

2017

13'786

1'776

245

287

63

17

85

51

55

49

741

1'336

385

3

3

41

131

120

11

12

1

1

4

21

2

1

1

411

Leistungsstatistik Kardiologie UniversitŠtsspital

07

2014

12'127

631

165

273

61

19

87

52

53

n.a.

581

1'193

364

n.a.

2

47

107

77

30

18

n.a.

n.a.

n.a.

7

4

n.a.

2

363

2015

11'473

1'842

208

283

77

15

125

47

57

n.a.

646

1'279

422

n.a.

1

27

103

85

18

13

n.a.

n.a.

1

11

5

n.a.

1

389

2016

15'082

1'783

228

304

73

29

88

54

53

50

710

1'278

387

6

1

33

131

112

19

15

4

n.a.

1

9

n.a.

2

n.a.

331

Bruderholzspital

Ruhe-EKG Langzeit-EKG (24-h) R-Tests Ergometrien Echokardiographie, transthorakal Echokardiographie, transoesophageal Stressechokardiographie Myokardperfusionsszintigraphie (in Zusammenar. m. Radiol.) MRI (in Zusammenarbeit mit Radiologie) BD-Messung (24-h) Schrittmacherkontrollen inkl. ICD Schrittmacherimplantationen inkl. -wechsel Kardioversionen StationŠre Konsilien

Service de Cardiologie Hopital du Jura

ErgometrienEchokardiographie, transthorakalEchokardiographie, transoesophagealMRIEKGR-TestSchrittmacherimplantationenElektrodenentfernungen/Repositionierung Loop recorder Implantation Loop recorder KontrolleSchrittmacherkontrollenICD-KontrollenHolter 24 h Blutdruckmessungen

2017

10'922748

32338

1'6946422865783

6734940

726

2624

3054

3522

2810

12

17719

1945

Leistungsstatistik PartnerspitŠler

Dienstleistungen

01 Dienstleistungen

08

2014

10'936553

34329

1'9179323

1277182

8287242

867

174673

1379

8259

2414

n.a.n.a.340

29n.a.n.a.

2015

11'539633

38340

1'9488325

11978

118828

6744

735

136537

484

424123117

n.a.n.a.374

36n.a.n.a.

2016

10'385547

54454

1'9427222

1237058

7266250

782

n.a.378

829

27254

11n.a.n.a.171

9139n.a.

Leistungsstatistik Herzchirurgie UniversitŠtsspital

Prozeduren

Operationen mit Herz-Lungen-Maschine (HLM)

Operationen ohne Herz-Lungen-Maschine (HLM)

Sonstige Operationen (Schrittmacher, ICD, Perikard, etc.)

Kombinationseingriffe (Herzoperationen mit HLM)

Bypasschirurgie

Aortokoronarer Bypass (AKB) isoliert mit HLM

Aortokoronarer Bypass (AKB) ohne HLM ("OPCAB")

Kombinationseingriffe (AKB+)

Aortenklappenchirurgie

Aortenklappenersatz biologisch

Aortenklappenersatz mechanisch

Aortenklappenrekonstruktion mit Eigenperikard (OP nach Ozaki)

Aortenklappen- und Wurzelersatz ("Composite")

Aortenklappenrekonstruktion

Transapikaler Aortenklappenersatz (ohne HLM, mit Kardiol.)

Mitralklappenchirurgie

Mitralklappenersatz mit HLM

Mitralklappenrekonstruktion mit HLM

Rekonstruktionsrate (geplant vs. durchgefŸhrt)

Andere

Trikuspidal- und Pulmonalklappenchirurgie

Trikuspidalklappenrekonstruktion

Pulmonalklappenersatz

2017

1061

535

99

233

229

319

165

20

134

225

107

28

10

30

29

16

121

32 (26/6)

85 (42/43)

97%

4

26

24

2

09

2014

1'157

631

112

210

210

417

234

50

132

273

167

39

n.a.

35

36

31

117

31

85

n.a.

n.a.

15

14

1

2015

1031

568

101

195

195

345

208

29

110

208

119

34

8

23

25

18

133

43(40/3)

87 (43/44)

97%

3

16

16

0

2016

1098

533

121

196

198

313

168

27

116

234

127

35

15

13

24

19

121

46 (43/3)

73 (33/40)

98%

2

12

11

1

Operationen an der thorakalen Aorta

Sonstige Eingriffe

Vorhofablation/Pulmonalvenenisolation

Vorhofseptumdefekt

Extrakorporale Zirkulation (EKZ)

Minimalisierte EKZ ("MECC")

Hypothermer Kreislaufstillstand

Kardiale UnterstŸtzungssysteme

Intraaortale Ballonpulsation (IABP)

Extrakorporale Membranoxygenation (ECMO)

LVAD (Destinationstherapie)

Eingriffsdringlichkeit

Elektiv

Notfall

Dringlich

Konsile Kardiologie

2017

105

51

15

36

535

145

90

51

21

22

8

577

122

77

308

2015

87

50

16

34

568

196

71

61

42

19

2

504

135

141

269

Leistungsstatistik Herzchirurgie UniversitŠtsspital

Dienstleistungen

01 Dienstleistungen

10

2014

104

53

21

32

631

232

79

53

31

22

n.a.

530

89

80

n.a.

2016

82

48

10

38

533

146

74

49

28

21

3

567

154

129

285

11

Outcome Statistik

Die medizinische QualitŠt ist zentraler Fokus bei den von der Kardiologie des USB angebotenen Leistungen. Gerade in Zeiten einer rasanten Entwicklung vor allem in technischen Bereichen der Medizin ist die exakte und lŸckenlose Aufarbei-tung von Komplikationen und TodesfŠllen, welche im Spital auftreten (In-hospital Mortality) von enormer Wichtigkeit. Im Rahmen der QualitŠtskontrolle der Abteilung Kardiologie erfolgt eine systematische Erfassung aller Eingriffe, welche im Laufe eines Jahres durchgefŸhrt werden. Basierend auf interdisziplinŠren Besprechungen im Rahmen von sogenannten Morbidity&Mortality Konferenzen (M&M) wird dabei nicht nur die In-hospital Mortality sondern auch die Procedure-related Mortality ermittelt. Beides sind wichtige Messgršssen in der QualitŠtskontrolle, welche die Kardiologie des USB seit mehre-ren Jahren transparent rapportiert.In der untenstehenden Tabelle sind alle TodesfŠlle aufgelistet, die nach einer kardiologischen Intervention aufgetreten sind. Hierzu ist anzumerken, dass dabei auch TodesfŠlle rapportiert werden, welche nicht kausal mit der Intervention zusammen-hŠngen. Deshalb wird zusŠtzlich auch die procedure-related Mortality rapportiert.

Anzahl

Untersuchungen

1'336

1'145

151

741

350

136

55

17

156

15

62

In-hospital Tod

N (%)

42 (3.1%)

33 (2.9%)

4 (2.6%)

0

2 (0.6%)

0

0

1 (5.9%)

1 (0.6%)

0

1 (1.6%)

Procedure-related Tod

N (%)

3 (0.2%)

1 (0.1%)

3 (2.0%)

0

0

0

0

0

0

0

0

Untersuchungstyp

PTCA / Stentimplantationen

Linksherzkatheter (ohne PTCA)

Interventionelle Klappeneingriffe *

Katheterablationen

Schrittmacher-Implantationen

Schrittmacher-Wechsel/-revision

ICD-Implantationen

ICD-Wechsel/-revision

CRT-ICD / CRT-PM

Elektrodenextraktion

Rechtsherzkatheter

Biopsie

ASD/PFO-Verschluss

* TAVI (n=131, davon 117 transfemoral), Valvuloplastien der Aortenklappe oder Mitralklappe (AVP: n=3, MVP: n=2), Mitraclip (n=12), indirekte Mitralklappenannuloplastie (n=1), direkte Mitralklappenannuloplastie (n=1), Verschluss paravalvulŠres Leck (n=1)

12 13

Dienstleistungen

01 Dienstleistungen

Interventionelle Kardiologie

Team

�rztliches Team

Prof. Christoph KaiserProf. Raban JegerDr. Gregor Fahrni

Wissenschaftliches Team

Dr. Nicole GilgenAndrea Harder-AllgšwerFranziska JordanMargarete Baumgartner

02 Kardiologie

14

Elektrophysiologie

Team

�rztliches Team

Prof. Christian SticherlingProf. Stefan OsswaldPD Dr. Michael KŸhnePD Dr. Tobias ReichlinProf. Beat SchŠr

Technisches Team

Dr. Sven KnechtFlorian Spiess

Team Schrittmacher/ICD Sprechstunde

Christine HuldiAndrea Mussler

Wissenschaftliches Team

Sarah GiesebartGian Všllmin

15

Echokardiographie

Team

�rztliche Mitarbeiter Echokardiographie

Prof. Beat KaufmannProf. Michael ZellwegerPD Dr. Otmar PfisterPD Dr. Daniel ToblerDr. Thilo BurkardDr. Marc Fischer Dr. Philipp HaafDr. Arnheid KesselDr. Wanda KloosDr. Jens LohrmannProf. Christine Meyer-ZŸrnDr. Karsten MurrayDr. Frank-Peter Stephan

Mitarbeiter Cardiovascular Molecular Imaging

Prof. Beat KaufmannDr. Amanda Ochoa-EspinosaDr. Mukesh PunjabiDr. Lifen XuDr. David Steinl Alexandra Kosareva

02 Kardiologie

16

Cardiac Imaging

Team

Prof. Michael ZellwegerDr. Thilo BurkardDr. Philip HaafDr. Patrick BadertscherKollaboration mit Radiologie und Nuklearmedizin

1717

Herzinsuffizienz

02 Kardiologie

18

Dr. Ina FerelBrigitte FitzeRomy MayrStephanie DšrflingerKristin ShresthaClaudia Stelzig

Team

�rztliches Team

PD Dr. Otmar PfisterProf. Christian MŸllerProf. Martin GrapowProf. Peter RickenbacherPD Dr. Gabriela Kuster PfisterProf. Michael ZellwegerDr. Jens LohrmannDr. Thilo Burkard

VAD-Koordination

Simon ScheifeleMarcel Henz

Herzinsuffizienzberatung / Studien

Lukas Weibel (ANP)Salom� RŸmmlerDr. Beate HartmannDayana FloresDr. Samyut ShresthaJonas Schwarz

19

KardiovaskulŠre PrŠvention / GUCH

Team KardiovaskulŠre PrŠvention / Hypertonie � Standort USB-MedPol

Dr. Thilo BurkardDr. Andrea MeienbergDr. Corinna KlŸberDr. Annina VischerDr. Elena Lardi, AA (1.7. bis 31.12.17)Dr. Maria-Luisa de Perna, AA (ab 1.7.17)Dr. Marc HŠfliger, AA (1.1. bis 31.3.17)Dr. Rupprecht Lange (1.4. bis 30.6.17)Dr. Pietro Lardelli (ab 1.10.17)Dr. Delphine Glinz-MagnenatDr. Leo Killian

Team GUCH / Angeborene Herzfehler

PD Dr. Daniel ToblerKetina ArslaniProf. Birgit DonnerLukas NotzNico RofflerGaby Frey

Rauchstopp-Beraterinnen:Uta EnglerNathalie Klaus

Blutdruckassistentinnen:Valerie JunghaenelOlivia ZahnSimone Erne

KARAMBA (Kardiale Rehabilitation)

02 Kardiologie

20

Team

�rzte

PD Dr. Otmar PfisterDr. Thilo BurkardDr. Karsten MurrayDr. Marc FischerDr. Manuela Florence BernoulliDr. Cornelia GanzoniDr. Rupprecht LangeDr. Roger Moser (Psychosomatik)

Pflege/Administration

Antonia CandelaGaby FreySarah Rigling

Sporttherapie

Madeleine Wick (Leitung)Julia LŠderachStephanie RuchFabienne SchneiderRuth Ostertag

Livia GrafTheresia KohlerAndrea Iris Bannwart

Physiotherapie

Yolanda Sanchez (Leitung)Kevin VogelPatrick ProbstNatali Marjanovic

Aquagymnastik

Monika RšthlisbergerTanja Biedermann

Herzinsuffizienzberatung

Lukas Weibel (ANP)Salom� RŸmmler

Kurzzeitklinik/Pflege/MTRA

Team KUK (Station 8.2)

Susanne TimusCatherine MalgatProf. Christian MŸllerDr. Wanda KloosDr. Jens Lohrmann

Team Pflege / MTT

Rosemarie BŸhrerDr. Sven Knecht Sšren LorenzClaudia LutzPaul BlindStephan Griessbach (ab 02.01.17) Jšrg Hassler (ab 01.04.17 temporŠr)Constance Deininger (bis 31.12.17)Brigitte Wiedmer (bis 31.12.17)Klaus Peter Gunsch (bis 31.12.17)Norman BaumgŠrtel (bis 30.04.17)Christine Huldi Andrea MusslerAntje HenkeAlice Wingerdt Bettina Andris Gabriela Rigotti (ab 01.04.17Nadine Mansueto (ab 01.09.17)Nicole KunstKristina Valaityte Daniele Minio Annette BusHeidi Linder Claudia KernbachBrigitta SorgNecla Demir (bis 30.04.17)Ayse Ulu (ab 01.09.17)Iris Klostermann (ab 01.11.17)

Team MTRA

Severine Dziergwa Nadine Ruettener Manuel Reidy Selina Botta Lea BurriStefan de Vries FrŠnzi Giger Barbara ImfeldMatthias Merz Katja Obhues Christine Orsingher Salome Seppi Kathrin Waidele Gina Wietschorke Feride Yesilyayla

21

Administration / Controlling

Team

Arton JusajRocio AlvarezEla AriBilal BektasMelanie JostJolanda MŸllerSarah RiglingAleksandra SchweizerChristina SchottGaby SchwobUrsula VogtHrvoje Vukovic

02 Kardiologie

22 21

Outcome Forschung

Team

Prof. Christian MŸllerDr. Ayman AlhussiniDr. Patrick BadertscherSanela BaracSara BarataPatrick BergsmaDr. Jasper BšddinghausDominik BreitenbŸcherLukas CrotonSebastian DietscheStephanie DšrflingerJeanne du Fay de LavallazPaul DuweDr. Ina FerelBrigitte FitzeDayana Flores GonzalesMichael FreeseMarc GeigerDominic GermanierBettina Glatz Dr. Beate HartmannNatascha Herr

02 Kardiologie / Klinische Forschung

Jonas HiltiUrsina HoneggerClaudia HuckRahel IsenrichJanina JannElif KeserIrina KlimmeckChristine KruseCaroline KulungaraDanai LaohachewinSabrina LauleSarah LšffelStella MarbotRomy MayrKathrin MeissnerFabiola M�tryDeborah MŸllerJulian PfŠffliDr. Christian PuelacherLea A. RichterichMarkus RiestererTherese Rinderknecht

Lorraine SazgaryDeborah SchneiderCarmela SchumacherJonas SchwarzDaniela SeebergerDr. Samyut ShrestaKristin ShrestaClaudia StelzigDr. Ivo StrebelKathrin ThommenDevran TopyŸrekMichael TschukJanine VšgeleJonas Elias WalterDesiree WusslerAna Yufera SanchezAndres Zimmerli

23

24

Swiss-AF Cohort Study

Team

Swiss-AF Cohort Study

Prof. Stefan OsswaldPD Dr. Michael KŸhneProf. Christian SticherlingProf. Christine Meyer-ZŸrnProf. David Conen Dr. Stefanie AeschbacherDr. Steffen BlumDr. Thomas KoflerDr. Philipp KrisaiDr. Christiane PudenzDr. Tobias SchšnDr. Anne Springer Sebastian BergerRaffaele BernasconiLucien EggimannLorin FršhlichTobias Gšldi Pascal Meyre

02 Kardiologie / Klinische Forschung

Michel MongiatAndreas ReusserAleksandra SchweizerSamuel StempfelGian Všllmin Von der CTU

Dr. Michael CoslovskyPascal BenkertPatrick Simon

23

Cardio Biology Team

Prof. Marijke BrinkChristian MorandiLifen XuPhilippe HeimGian R. Brouwer (seit Sept 2017)Hagena Thuraisingam (seit Sept 2017)Sonia Lebboukh (bis Okt 2017)Joseph Iharinjaka Randriamboavonjy (bis Sept 2017)

Myocardial Research Team

PD Dr. Gabriela Kuster PfisterPD Dr. Otmar PfisterVera Lorenz, M. Sc. Dr. Lifen XuDr. Michika Sato MochizukiGiacomo Della Verde, M. Sc. Daria Monogiou Belik, M. Sc.

Molecular Imaging Team

Prof. Beat KaufmannDr. Amanda Ochoa-EspinosaDr. Mukesh PunjabiDr. Lifen XuDr. David Steinl Alexandra Kosareva, M. Sc.

02 Kardiologie / Grundlagenforschung

25

Klinik fŸr Herzchirurgie

Team

�rzte

Prof. Friedrich Eckstein PD Dr. Oliver Reuthebuch Prof. Martin Grapow Dr. Florian RŸter PD Dr. Denis Berdajs Dr. Ulrich Schurr Alejandro Ramirez (01- 06/17) Rosalinda D`Amico (06 -12/17)

IMC Chirurgie

Dr. Pierre Branitzki (bis 05/17) Mairi Ziaka (ab 06/17)Dr. Clemens Dovifat Dr. Karin Fuhrmann-Hilbrecht Christina Ignat (ab 06/17)

03 Herzchirurgie

Fachassistenten Herzchirurgie

Andre Capitain (ab 08/17)Dr. Luca KoechlinAdriatik Komoni (04 - 07/17)Dr. Myroslava MytsykThibault Schaeffer (ab 12/17)Dr. Jasmin Hasmik Shahinian

Rotationsassistenten Chirurgie

Vladislav Borisov

Rotationsassistenten Kardiologie

Dr. Patrick Badertscher Dr. Marc HŠfliger

Rotationsassistenten Innere Medizin

Dr. Jasper BšddinghausLilian PichlerDr. Milos Radosavac

26 27

28

Klinik fŸr Herzchirurgie

Team

Physician Assistants

Waldemar GerrMahtab Jamshidpour (bis 06/17)

Kardiotechniker

Thomas DšbeleClaudia EndresSelin Korac (ab 08/17)Bejtush RrhamaniDr. Antoine Simons (bis 07/17)Urs Zenklusen

Forschungsgruppenteam

PD Dr. Anna MarsanoGiulia Cerino, PhDGiuseppe Isu, PhD Dr. Vladislav Borisov Dietlinde John-Steinberg Laia Gili Sole, MSc Alessia Pisanu, BSc Diana Robles Diaz Chirurgische Intermediate Care Station (IMC)

Vitomir JankovicAlexandra Murst

03 Herzchirurgie

Chirurgische Station 4.1

Marcel Hentz Fr�d�rique Foell Stv. Pflegedienstleitung (seit 06/17)Simon Scheifele (bis 05/17)Karin Steiger Alice Stšlke

Chirurgische Station 7.1

Sibylle Waldmann Silvia Violante

Sekretariat

Jolanda Giess Miriam Boughalmi Laura Voegeli Biljana Marti (ab 08/17) Brigitta Gahl (ab 06/17) Petra Vocat (bis 06/17) Bettina Kohler

2729

3130

Notfallzentrum

Team

�rzte Kader

Prof. Roland BingisserPD Dr. Christian NickelDr. Christoph BeckerDr. Michelle BrŠutigam Dr. Vera Freund Dr. Gerhard JŠckhDr. KriemhildLippayDr. Gregory MansellaDr. Caroline Polzer Dr. Elisabth RatzenbšckDr. Christiane RosinDr. Jana Steude Dr. Irena Straub Dr. Birgit WernerDr. Christian Beca Dr. Luc BlattmannDr. Nicolas Bless Dr. Peter Diel Dr. Gilbert KrŠhenbŸhl Dr. Sebastian MŸller

04 Notfallzentrum

Dr. Jochen RŸdiger Dr. Britta BussDr. Sonja CronenbergDr. Maria Gšttl

Pflege Kader

Katharina MatheisFranziska ImmbodenKai LŸbenDebbis AllenLilly Gavric

Administration

Monika Stadler

Contolling

Artur Stickel

Medizinische Intensivstation

Team

�rzte

Prof. Stephan Marsch Prof. Patrick Hunziker Dr. Andreas Christ Dr. Kai Tisljar Dr. Gianmarco Balestra Dr. Jorge KasperDr. Heidi LedererDr. Magnus StalderPD Dr. Raoul Sutteri

05 Medizinische Intensivstation

32

Pflege

Angelika Lehmann Monika Strohmeier Sabine Hiller Lukas Weibel Christian Emsden Marie-Noelle von AllmenJos� Lopes

Sekretariat

Deborah Minnig Silvia Habegger

33

34

KardioanŠsthesie

Team

�rzte

PD Dr. Jens Fassl PD Dr. Daniel Bolliger Dr. Joachim Erb Dr. Markus Maurer Dr. David Heppel Dr. Stefan Gisin Dr. Andreas Lampart Dr. Jonas Quitt Dr. Dominik Kallias

Pflegeteam

Isabelle Gisler Elisabeth Goustiaux Michael Gregor

06 KardioanŠsthesie

35

37

Operative Intensivbehandlung (OIB)

Team

�rzte

Prof. Hans ParggerProf. Martin SiegemundDr. Nadine CueniDr. Jan BittnerDr. Anita BoltresPD Dr. Andrea Kopp LugliDr. Andreas LŸdinDr. Benjamin MŸllerDr. Carole RimpauDr. Daniel TuchschererDr. Marianne Zumbrunn

07 Operative Intensivbehandlung (OIB)

36

Pflege

Michael WehrliClaudia SpychigerUrsula Barandun SchŠferConrad Wesch

Sekretariat

Janine Anliker

Lehre

08 Lehre

Weiter- und Fortbildungs-Veranstaltungen

Externe Weiter- und Fortbildung¥ Regionale Fortbildungskurse (Rheinfelden / Bad Bubendorf)

Interne Weiter- und Fortbildung¥ CCU-Rapport, tŠglich 08.00 Uhr¥ Kardiologie, Montag 08.15 Uhr¥ Herzchirurgie, Montag 07.30-08.00 Uhr¥ Departements Konferenz Chirurgie, Montag 08.10-9.00 Uhr¥ Echokardiographie Fortbildung, Montag 12.30-13.30 Uhr¥ Kardiochirurgisches und -medizinisches Meeting, Montag 17.00 Uhr¥ Curriculum AA, Dienstag 7.45 Uhr¥ Seminar KardiovaskulŠre Grundlagenforschung, 1x Monat, alternierend Mo 09.00-10.00 Uhr, bzw. Di 14.00-15.00 Uhr¥ Herzinsuffizienz Lunch, jeweils jeden dritten Dienstag im Monat 12.30-13.30 Uhr¥ Kardiochirurgisches und -medizinisches Meeting, Mittwoch, 17.00 Uhr¥ Kardio-Lunch, Donnerstag 12.30-13.30 Uhr¥ Journal Club, Freitag 08.15-9.00 Uhr¥ Mortality & Morbidity Conference, 1 x Monat, Freitag 12.30-13.30 Uhr¥ Problemorientierte Fall Tutorate (2. Jahreskurs Medizinische FakultŠt Basel)¥ Arzt-Patienten-Unterricht (4. und 6. Jahreskurs Medizinische FakultŠt Basel)

Selbstorganisierte Kongresse / Symposien der Kardiologie Basel

¥ medArt 2017, Juni 2017, Basel¥ EuroGuch Lausanne, 4.-6. Mai 2017¥ InteruniversitŠres GUCH-Kolloquium, 21. September 2017

Kongresse / Symposien mit Basler Hauptorganisation

¥ Basel Valve Summit 27.4.2017 (Prof. R. Jeger)¥ GREAT Meeting Rom, Juli 2017¥ "New Swiss Horizon" Electrophysiology-meeting Lenzerheide, 22./23.09.2017 ¥ DreilŠndertreffen Herzinsuffizienz Thun, 21.-23. September 2017¥ EKG Kurs fŸr Assistenten, 26./27.10.2017, Basel¥ EHRA Education Course - Implantable Cardioverter Defibrillator Module, Berlin, 16./17.11.2017

38

Einsitz in Standesorganisationen

¥ Prof. B. Kaufmann PrŠsident Arbeitsgruppe Echokardiographie und kardiovaskulŠre Bildgebung Mitglied Board Arbeitsgruppe kardiovaskulŠre Biologie Mitglied Finanzkommission SGK¥ Dr. T. Burkard: Revisor Schweizerische Hypertoniegesellschaft¥ Prof. F. Eckstein: VizeprŠsident im Vorstand der Schweizerischen Gesellschaft fŸr Herz- und Thorakale GefŠsschirurgie¥ Prof. R. Jeger: SGK Working Group Interventional Cardiology, Board Member¥ PD Dr. M. KŸhne Vorstandsmitglied Arbeitsgruppe Herzschrittmacher und Elektrophysiologie der SGK Ambassador for young electrophysiologists der EHRA (European Heart Rhythm Association)¥ PD Dr. G. Kuster Pfister: Mitglied Fachgruppe Frau & Herz der Schweiz. Herzstiftung, Cardiolinc Network, Member Board of Directors¥ Prof. Ch. MŸller Leiter, Dissertationsauszeichnungskommission der Medizinischen FakultŠt Basel European Society of Cardiology, Heart Failure Association, Board Member European Society of Cardiology, Biomarker Study Group, Member European Society of Cardiology, Acute Cardiovascular Care Association, Acute Heart Failure Study Group, chair European Society of Cardiology, Heart Failure Association, Committee on Diagnosis, chair European Society of Cardiology, Heart Failure Association, Committee on Acute Heart Failure, member GREAT Network, Vice president¥ PD Dr. O. Pfister: Past President Arbeitsgruppe Herzinsuffizienz der Schweizerischen Gesellschaft fŸr Kardiologie¥ PD Dr. O. Reuthebuch: Beisitzer im Vorstand der Schweizerischen Gesellschaft fŸr Herzchirurgie¥ Prof. B. SchŠr: Curriculumskommission der medizinischen FakultŠt Basel¥ Prof. C. Sticherling Mitglied des Scientific Writing Committees der European Heart Rhythm Association (EHRA) Past-PrŠsident der AG Herzschrittmacher und Elektrophysiologie der SGK Mitglied der Tarifkommission der SGK¥ PD Dr. D. Tobler Vorstandsmitglied WATCH (Working group teenager and adults with congenital heart disease) Vorstandsmitglied und PrŠsident herznetz.ch (Dachverband angeborene Herzfehler)¥ Prof. M. Zellweger: PrŠsident der SGK

Ausbildung

¥ Prof. M. Brink: Themenblockleiterin: Themenblock Herz Kreislauf, 2. Bachelor Studienjahr Themenblock Co-Leiterin, 1. Master Studienjahr Physiologie-Professorin (Vorlesungen, Praktika, Tutoriate)¥ Prof. M. Grapow: Tutoriat 1. JK, Betreuung von 3 Master Studenten, Betreuung von 1 Doktorandin¥ PD Dr. O. Reuthebuch: Betreuung von 2 Master Studenten¥ Prof. C. MŸller: Betreuung von 10 Masterstudenten / Tutoriat 4. JK / Betreuung von 14 Doktoranden¥ PD Dr. D. Tobler: Betreuung von 2 Masterstudenten¥ Prof. Ch. Kaiser, Prof. R. Jeger, PD Dr. T. Reichlin, Prof. B. SchŠr, PD Dr. C. Kuster Pfister: PrŸfer Staatsexamen¥ Prof. B. SchŠr: Themenblockorganisator¥ Prof. Ch. Sticherling, Prof. S. Osswald, Prof. B. SchŠr, PD Dr. M. KŸhne, PD Dr. T. Reichlin: EKG Kurs 39

Finanzielles

09 Finanzielles

ForschungsbeitrŠge

Schweizer Nationalfonds

¥ SNF Projektfšrderung 310030_149718: Kaufmann B. Non-invasive ultrasound molecular imaging of myocarditis and autoimmune myocardial inflammation Beginn: 01.04.2014 / 3 Jahre¥ SNF Projektfšrderung 310030_169905: Kaufmann B. Non-invasive ultrasound molecular imaging of atherosclerosis: development of a clinically translatable tracers for targeting of vascular cell adhesion molecule Beginn 01.01.2017 / 3 Jahre¥ SNF Professur Nr: PP00P3_133681: Conen D.: Risk factors and outcomes associated with the progression of human atrial fibrillation: Role of Inflammation, Oxidative Stress and Fibrosis in the Initiation and Progression of Human Atrial Fibrillation: 2011-2016 Beginn: 01.07.2011 / 5 Jahre¥ SNF Projektfšrderung 310030-169996: Brink M "Gender-specific mechanisms of cardiac dysfunction in obesity" Beginn 01.10.2016 / 3 Jahre¥ SNF Projektfšrderung 33IC30_166855/1: Tobler D. Effect of phosphodiesterase-5 inhibition with tadalafil on systemic right ventricular function - a multi-center, double-blindrandomized, placebo-controlled clinical trial Beginn: 01.01.2017 / 5 Jahre¥ SNF Projektfšrderung 156953: Kuster G./Pfister O. Regulators of cardiac progenitor cells: Focus on cancer drug targets Beginn / Dauer: 1.1.2016 / 3 Jahre¥ SWISS-AF (Longitudinal Studies): 33CS30_148474: Conen D., KŸhne M., Osswald S. Swiss Atrial Fibrillation Cohort Study Beginn: 01.03.2014 / 4 Jahre¥ SNF Projektfšrderung 310030_172989: Marsano A. Engineered patches for cardiac repair Beginn: 01.04.2017 / 4 Jahre ¥ SNF Projektfšrderung Nr. 32003B_159495/1: MŸller C. APACE Validation Beginn: 01.01.2016 / 3 Jahre¥ SNF Projektfšrderung 32003B_175604/1: MŸller C. BASEL IX Validation Beginn: 1.10.2017 / 3 Jahre¥ SNF Projektfšrderung Nr. 32473B_176178: KŸhne M. Health Consequences of the Burden of Atrial Fibrillation (Swiss-AF-Burden) Beginn: 01.10.2017 / 4 Jahre

40

EU-Grants

¥ 2013 European Union FP7-Health_2013_Innovation 1 (Project 602299), Sticherling C. EU-CERT-ICD Comparative effectiveness research to assess the use of primary prophylactic implantable cardioverter defibrillators in Europe Beginn: 1.10.2013 / 4 Jahre¥ European Union/Eurostars "E!9799 ALVALE, Anatomical Localization of the origin of Ventricular Arrhythmias from the 12-Lead ECG", Reichlin T Beginn: 01.01.2016 / 3 Jahre¥ European Union/Eurostars: Cebris, MŸller C. Combination of classical and high-frequency ECG with Biomarkers into a RiskScore for Exercise ECG Beginn: 01.10.2017 / 3 Jahre

Schweizerische Herzstiftung

¥ Rubini-G. M: Addressing gender-specific inequalties in the early diagnosis and management of acute cardiovascular diseases Beginn: 01.11.2016 / 1 Jahr¥ MŸller C.: Advantageous predictors of acute coronary syndromes evaluation (APACE, Phase III) Beginn: 01.11.2016 / 1 Jahr¥ Reichlin T.: Value of novel advanced 12-lead ECG markers for the selection of patients undergoing ICD implantation for primary prevention of sudden cardiac death Beginn: 01.01.2017 / 1 Jahr¥ KŸhne M.: Swiss-AF-Burden: Rhythm monitoring using 7-day ECG and implantable loop recorders Beginn: 1.10.2017 / 2 Jahre

Stiftung fŸr kardiovaskulŠre Forschung Basel

¥ Brink M., Burkard T., Conen D., Jeger R., Kaiser C., Kaufmann B., Kuster Pfister G., MŸller C., Pfister O., Reichlin T., Sticherling C., Zellweger M.

ForschungsbeitrŠge UniversitŠt Basel

¥ Mochizuki M.: Stay-on-track Beginn / Dauer: 01.08.2017 / 6 Monate

41

Finanzielles

09 Finanzielles

Andere Quellen / Stiftungen

¥ Goldschmidt-Jacobsen-Stiftung T. Reichlin: Refinement and Integration of Advanced ECG Technologies in Clinical Cardiology Beginn / Dauer: 1.4.2015 / 3 Jahre J. du Fay de Lavallaz: BASEL IX Beginn: 01.01.2017 / 1 Jahr¥ Kahane Foundation / Fondation Sana / Gesundheitsdepartement Basel-Stadt T. Burkard: "Nichtrauchen ist clever!" Fšrdermittel 2017

Andere Quellen / Industrie

¥ Abbott: Advantageous predictors of acute coronary syndromes evaluation (APACE), (MŸller C.) BASEL VIII (MŸller C)¥ BASEL-PMI (MŸller C)¥ Beckman Coulter: APACE (MŸller C)¥ Biomerieux: Advantageous predictors of acute coronary syndromes evaluation (APACE), (MŸller C.)¥ BRAHMS: Advantageous predictors of acute coronary syndromes evaluation (APACE), (MŸller C.) BASEL IX - Basel Syncope Evaluation Study (MŸller C.) BASEL V - Acute dyspnea (MŸller C.)¥ B. Braun Melsungen AG: BASKET-SMALL 2-Studie (Jeger R.)¥ Roche: Advantageous predictors of acute coronary syndromes evaluation (APACE), (MŸller C.) BASEL V - Acute dyspnea (MŸller C.) GALACTIC (MŸller C.)¥ Siemens: Advantageous predictors of acute coronary syndromes evaluation (APACE), (MŸller C.)¥ Singulex: Advantageous predictors of acute coronary syndromes evaluation (APACE), (MŸller C.) BASEL VII - Acute Abdominal Pain (MŸller C.) Biochemical and electrocardiographic signatures to detect exercise-induced myocardial ischemia (MŸller C.) BASEL V, BASEL VIII, BASEL IX (MŸller C.)¥ VFWAWF-Pool RŸckkehrer-Stipendium, (Fahrni G.)

42

Sponsoren und Gšnner

¥ Abbott AG¥ Actelion Schweiz¥ A. Menarini AG¥ AstraZeneca AG¥ Bayer (Schweiz) AG¥ Biosense Webster¥ Biotronik Schweiz AG¥ Boehringer Ingelheim ¥ Boston Scientific¥ B.R.A.H.M.S. GmbH¥ B. Braun Melsungen AG¥ BŸhlmann Laborator AG¥ concile¥ Cordis Johnson & Johnson¥ Daiichi Sankyo (Schweiz) AG¥ 8sens biognostics GmbH¥ Edwards Life Science AG¥ Eli Lilly (Suisse) SA¥ Fšrderverein Kardiologie Basel¥ GlaxoSmithKline AG¥ GrŸnenthal Pharma AG¥ Guidant Europe SA¥ IBSA¥ J.C. General Serv. CVBA¥ Johnson & Johnson

¥ Medtronic (Schweiz) AG¥ mepha¥ Merck Sharp & Dohme¥ Mundipharma Medical Company¥ Novartis AG¥ novo nordisk¥ Nycomed Pharma AG¥ Pfizer AG¥ Robapharm AG¥ Roche¥ Sandoz Pharmaceuticals AG¥ Sanofi Aventis SA¥ Schwabe Pharma AG¥ Sigma-Tau Pharma AG¥ Stentys ¥ Stiftung fŸr kardiovaskulŠre Forschung Basel¥ St. Jude Medical (Schweiz) AG¥ Sorin ¥ Swiss Life AG¥ Takeda Pharma AG¥ Terumo ¥ The Medicines Company¥ Vifor Pharma¥ Viollier AG

43

Publikationen

Originalarbeiten

1. AbŠcherli R, Twerenbold R2, Boeddinghaus J2, Nestelberger T2, MŠchler P2, Sassi R3, Rivolta MW3, Roon izi EK3, Mainardi LT4, Kozhuharov N5, Rubini Gim�nez M2, Wildi K2, Grimm K2, Sabti Z2, Hillinger P2, Puelacher C2, Strebel I2, Cupa J2, Badertscher P2, Roux I2, Schmid R6, Leber R6, Osswald S2, Mueller C, Reichlin T. Diagnostic and prognostic values of the V-index, a novel ECG mar-ker quantifying spatial heterogeneity of ventricular repolarization, in patients with symptoms suggestive of non-ST-elevation myocardial infarction. Int J Cardiol. 2017. Impact Factor 6.189

2. Aimo A, Vergaro G, Ripoli A, Bayes-Genis A, Pascual Figal DA, de Boer RA, Lassus J, Mebazaa A, Gayat E, Breidthardt T, Sabti Z, Mueller C, Brunner-La Rocca HP, Tang WH, Grodin JL, Zhang Y, Bettencourt P, Maisel AS, Passino C, Januzzi JL, Emdin M.

3. Akoudad S, Dabiri Abkenari L, Schaer BA, Sticherling C, Levy WC, Jordaens L, Theuns DA. Comparison of multivariate risk esti-mation models to predict prognosis in patients with implantable cardioverter defibrillators with and without cardiac resynchroniza-tion therapy. Am J Cardiol 2017. Impact Factor 3.398

4. Ambavane A, Lindahl B, Giannitis E, Roiz J, Mendivil J, Fran-kenstein L, Body R, Christ M, Bingisser R, Alquezar A, Mueller C; TRAPID-AMI investigators. Economic evaluation of the one-hour rule-out and rule-in algorithm for acute myocardial infarction using the high-sensitivity cardiac troponin T assay in the emergency de-partment. PLoS One. 2017. Impact Factor 2.806

5. Asgar A, Chandrasekhar J, Mikhail G, Webb J, Lef�vre T, Tam-burino C, Hildick-Smith D, Hambrecht R, Van Belle E, Widder J, Dumonteil N, Hink U, Jeger R, Linke A, Deliargyris E, Gao P, Mehran R, Hengstenberg C, Anthopoulos P, Dangas G; BRAVO-3 Investiga-tors. Sex-based differences in outcomes with bivalirudin or unfrac-tionated heparin for transcatheter aortic valve replacement: Results from the BRAVO-3 randomized trial. Catheter Cardiovasc Interv. 2017. Impact Factor 2.602

6. Bahrmann P, Bertsch T, Giannitsis E, Christ M, Hofner B, Chris-tenson R, Lindahl B, Mueller C. Quantification of Renal Function and Cardiovascular Mortality in Patients Admitted to the Emergency Department with Suspected Acute Coronary Syndromes. Clin Lab. 2017. Impact Factor 0.840

10 Publikationen

7. Beri N, Marston NA, Daniels LB, Nowak RM, Schreiber D, Muel-ler C, Jaffe A, Diercks DB, Wettersten N, DeFilippi C, Peacock WF, Limkakeng AT, Anand I, McCord J, Hollander JE, Wu AH, Apple FS, Nagurney JT, Berardi C, Cannon CM, Clopton P, Neath SX, Chris-tenson RH, Hogan C, Vilke G, Maisel A. Necessity of hospitalization and stress testing in low risk chest pain patients. Am J Emerg Med. 2017. Impact Factor 1.494

8. Blum S, Muff C, Aeschbacher S, Ammann P, Erne P, Moschovitis G, Di Valentino M, Shah D, SchlŠpfer J, Fischer A, Merkel T, KŸhne M Sticherling C, Osswald S, Conen D. Prospective assessment of sex-related differences in symptom status and health perception among patients with atrial fibrillation. J Am Heart Assoc 2017. Im-pact Factor 4.425

9. Boeddinghaus J, Nestelberger T, Twerenbold R, Wildi K, Badert-scher P, Cupa J, BŸrge T, MŠchler P, Corbi�re S, Grimm K, Gim�nez MR, Puelacher C, Shrestha S, Flores Widmer D, Fuhrmann J, Hil-linger P, Sabti Z, Honegger U, Schaerli N, Kozhuharov N, Rentsch K, Mir— ñ, L—pez B, Martin-Sanchez FJ, Rodriguez-Adrada E, Mora-wiec B, Kawecki D, Ganovská E, Parenica J, Lohrmann J, Kloos W, Buser A, Geigy N, Keller DI, Osswald S, Reichlin T, Mueller C. Direct Comparison of 4 Very Early Rule-Out Strategies for Acute Myocar-dial Infarction Using High-Sensitivity Cardiac Troponin I. Circulation. 2017 Impact Factor 19.309

10. Boeddinghaus J, Reichlin T, Nestelberger T, Twerenbold R, Meili Y, Wildi K, Hillinger P, Gim�nez MR, Cupa J, Schumacher L, Schu-bera M, Badertscher P, Corbi�re S, Grimm K, Puelacher C, Sabti Z, Widmer DF, Schaerli N, Kozhuharov N, Shrestha S, BŸrge T, MŠchler P, BŸchi M, Rentsch K, Mir— ñ, L—pez B, Martin-Sanchez FJ, Rodriguez-Adrada E, Morawiec B, Kawecki D, Ganovská E, Pa-renica J, Lohrmann J, Buser A, Keller DI, Osswald S, Mueller C. Early Diagnosis of Acute Myocardial Infarction in Patients with Mild Elevations of Cardiac Troponin. Clin Res Cardiol 2017. Impact Fac-tor 4.760

11. Bossard M, Knecht S, Aeschbacher S, Buechel R, Hochgruber T, Zimmermann A, Kessel-Schaefer A, Stephan FP, Voellmin G, Pra-della M, Sticherling C, Osswald S, Kaufmann B, Conen D, KŸhne M. Conventional versus 3D-echocardiography to predict arrhythmia re-currence after atrial fibrillation ablation. J Cardiovasc Electrophysiol 2017. Impact Factor 3.068

44

12. Bossard M, Th�riault S, Aeschbacher S, Schoen T, Kunz S, von Rotz M, Estis J, Todd J, Risch M, Mueller C, Risch L, Par� G, Conen D. Factors independently associated with cardiac troponin I levels in young and healthy adults from the general population. Clin Res Cardiol 2017. Impact Factor 4.760

13. Breidthardt T, Sabti Z, Ziller R, Rassouli F, Twerenbold R, Kozhuh-arov N, Gayat E, Shrestha S, Barata S, Badertscher P, Boeddinghaus J, Nestelberger T, Mueller C. Diagnostic and prognostic value of cystatin C in acute heart failure. Clin Biochem. 2017. Impact Factor 2.434

14. Breidthardt T, Moreno-Weidmann Z, Uthoff H, Sabti Z, Appeli S, Puelacher C, Stallone F, Twerenbold R, Wildi K, Kozhuharov N, Wussler D, Flores D, Shrestha S, Badertscher P, Boeddinghaus J, Nestelberger T, Gimenez MR, Staub D, Aschwanden M, Lohrmann J, Pfister O, Osswald S, Mueller C. How accurate is clinical assess-ment of neck veins in the estimation of central venous pressure in acute heart failure? Insights from a prospective study. Eur J Heart Fail. 2018. in press. Impact Factor 6.968

15. Breidthardt T, Weidmann ZM, Twerenbold R, Gantenbein C, Stallone F, Rentsch K, Rubini Gimenez M, Kozhuharov N, Sabti Z, BreitenbŸcher D, Wildi K, Puelacher C, Honegger U, Wagener M, Schumacher C, Hillinger P, Osswald S, Mueller C. Impact of Haemo-concentration during Acute Heart Failure Therapy on Mortality and its Relationship with Worsening Renal Function. Eur J Heart Fail 2017. Impact Factor 6.968

16. Brenner R, Ammann P, Yoon SI, Christen S, Hellermann J, Girod G, Knaus U, Duru F, Krasniqi N, Ramsay D, Sticherling C, Lippuner, KŸhne M. Reduction of falls and fractures after permanent pace-maker implantation in elderly patients with sinus node dysfunction. Europace 2017. Impact Factor 4.530 17. Burri H, MŸller H, Kobza R, Sticherling C, Ammann P, Zerlik H, Stettler C, Klersy C, Prinzen A, Auricchio A. Right versus left apical transvenous pacing for bradycardia: results of the RIVELA rando-mized study. Ind Pacing Electrophysiol J.

18. Burkard T, Winterhalder C, Leonardi L., Maseli A, Schoen T, Eck-stein J, Vischer AS. Missed arterial hypertension by office blood pressure measurement measured according to the NICE 2011 guidelines - Results from the iPARR trial. Journal of Hypertension 2017. Impact Factor 4.085

19. Caobelli F*, Haaf P*, Chronis J, Haenny G, Brinkert M, Pfisterer ME, Zellweger MJ; Basel Asymptomatic High-Risk Diabetics Out-come Trial (BARDOT) Investigators. Prognostic Usefulness of Cardi-ac Stress Test Modalities in Patients With Type 2 Diabetes Mellitus Who Underwent Myocardial Perfusion Scintigraphy (from the Basel Asymptomatic High-Risk Diabetics Outcome Trial). Am J Cardiol. 2017. Impact Factor 3.398

20. Celikyurt U, Knecht S, Kuehne M, Reichlin T, Muehl A, Osswald S, Sticherling C. Incidence of new-onset atrial fibrillation after cavo-tricuspid isthmus ablation for atrial flutter. Europace 2017. Impact Factor 4.530

21. Chapman A, Anand A, Boeddinghaus J, Ferry AV, Sandeman D, Adamson PD, Andrews J, Tan S, Cheng SF, D'Souza M, Orme K, Strachan FE, Nestelberger T, Twerenbold R, Badertscher P, Reichlin T, Gray A, Shah ASV, Mueller C, Newby DE, Mills NL. Comparison of the efficacy and safety of early rule out pathways for acute myo-cardial infarction. Circulation 2017. Impact Factor 19.309

22. Chapman AR, Lee KK, McAllister DA, Cullen L, Greenslade JH, Parsonage W, Worster A, Kavsak PA, Blankenberg S, Neumann J, Sšerensen NA, Westermann D, Buijs MM, Verdel GJE, Picke-ring JW, Than MP, Twerenbold R, Badertscher P, Sabti Z, Mueller C, Anand A, Adamson P, Strachan FE, Ferry A, Sandeman D, Gray A, Body R, Keevil B, Carlton E, Greaves K, Korley FK, Metkus TS, Sandoval Y, Apple FS, Newby DE, Shah ASV, Mills NL. Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome. JAMA. Review. Impact Factor 44.405

23. Cerino G, Gaudiello E, Muraro MG, Eckstein F, Martin I, Scher-berich A, Marsano A. Engineering of an angiogenic niche by perfu-sion culture of adipose-derived stromal vascular fraction cells. Sci Rep. 2017. Impact Factor 4.259

24. Conen D, Rodondi N, Mueller A, Beer J, Auricchio A, Ammann P, Hayoz D, Kobza R, Moschovitis G, Shah D, Schlaepfer J, Novak J, di Valentiono M, Erne P, Sticherling C, Bonati L, Ehret G, Roten L, Fischer U, Monsch A, Stippich C, Wuerfel J, Schwenkglenks M, Kuehne M, Osswald S. Design of the Swiss Atrial Fibrillation Cohort Study (Swiss-AF): structural brain damage and cognitive decline among patients with atrial fibrillation. Swiss Med Wkly 2017. Im-pact Factor 1.654

45

Publikationen

10 Publikationen

31. Fahrni G, Wolfrum M, De Maria GL, Cuculi F, Dawkins S, Alkhalil M, Patel N, Forfar JC, Prendergast BD, Choudhury RP, Channon KM, Banning AP, Kharbanda RK. Index of Microcirculatory Resis-tance at the Time of Primary Percutaneous Coronary Intervention Predicts Early Cardiac Complications: Insights From the OxAMI (Oxford Study in Acute Myocardial Infarction) Cohort. J Am Heart Assoc. 2017. Impact Factor 5.117

32. Ferko N, Ferrante G, Hasegawa JT, Schikorr T, Soleas IM, Hern-andez JB, Sabat� M, Kaiser C, Brugaletta S, de la Torre Hernandez JM, Galatius S, Cequier A, Eberli F, de Belder A, Serruys PW, Valgi-migli M. Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized tri-als. Catheter Cardiovasc Interv. 2017. Impact Factor 2.602

33. Fischer A, Bossard M, Aeschbacher S, Egli P, Cordewener C, Estis J, Todd J, Risch M, Risch L, Conen D., Plasma levels of endo-thelin-1 and renal function among young and healthy adults. Clin Chem Lab Med 2017. Impact Factor

34. Gaudiello E, Melly L, Cerino G, Boccardo S, Jalili-Firoozinezhad S, Xu L, Eckstein F, Martin I, Kaufmann BA, Banfi A, Marsano A. Scaffold Composition Determines the Angiogenic Outcome of Cell-Based Vas-cular Endothelial Growth Factor Expression by Modulating Its Microen-vironmental Distribution. Adv Healthc Mater. 2017. Impact Factor 5.110

35. Garg P, Broadbent DA, Swoboda PP, Foley JRJ, Fent GJ, Musa TA, Ripley DP, Erhayiem B, Dobson LE, McDiarmid AK, Haaf P, Ki-dambi A, van der Geest RJ, Greenwood JP, Plein S. Acute Infarct Extracellular Volume Mapping to Quantify Myocardial Area at Risk and Chronic Infarct Size on Cardiovascular Magnetic Resonance Imaging. Circ Cardiovasc Imaging. 2017. Impact Factor 6.803

36. Garg P, Broadbent DA, Swoboda PP, Foley JRJ, Fent GJ, Musa TA, Ripley DP, Erhayiem B, Dobson LE, McDiarmid AK, Haaf P, Ki-dambi A, Crandon S, Chew PG, van der Geest RJ, Greenwood JP, Plein S. Extra-cellular expansion in the normal, non-infarcted myo-cardium is associated with worsening of regional myocardial func-tion after acute myocardial infarction. J Cardiovasc Magn Reson. 2017. Impact Factor 5.601

37. Garg P, Kidambi A, Swoboda PP, Foley JR, Musa TA, Rip-ley DP, Erhayiem B, Dobson LE, McDiarmid AK, Fent GJ, Haaf P, Greenwood JP, Plein S. The role of left ventricular deformation in the assessment of microvascular obstruction and intramyocardial haemorrhage. Int J Cardiovasc Imaging. 2017. Impact Factor 1.896

25. De Boeck BW, Toma A, Kiencke S, Dehnert C, ZŸgel S, Sieben-mann C, Auinger K, Buser PT, Maggiorini M, Kaufmann BA. Altered left ventricular geometry and torsional mechanics in high altitude-induced pulmonary hypertension: a 3D echocardiographic study. J Am Soc Echocardiogr. Impact Factor 6.852

26. De Maria GL, Alkhalil M, Wolfrum M, Fahrni G, Borlotti A, Gaughran L, Dawkins S, Langrish JP, Lucking AJ, Choudhury RP, Porto I, Crea F, Dall‘Armellina E, Channon KM, Kharbanda RK, Ban-ning AP. The ATI score (age-thrombus burden-index of microcircula-tory resistance) determined during primary percutaneous coronary intervention predicts final infarct size in patients with ST-elevation myocardial infarction: a cardiac magnetic resonance validation stu-dy. EuroIntervention. 2017. Impact Factor 5.165

27. De Maria GL, Patel N, Wolfrum M, Fahrni G, Kassimis G, Porto I, Dawkins S, Choudhury RP, Forfar JC, Prendergast BD, Channon KM, Kharbanda RK, Garcia-Garcia HM, Banning AP. The influence of coronary plaque morphology assessed by optical coherence to-mography on final microvascular function after stenting in patients with ST-elevation myocardial infarction. Coron Artery Dis. 2017. Im-pact Factor 1.823

28. De Waard GA, Fahrni G, de Wit D, Kitabata H, Williams R, Patel N, Teunissen PF, van de Ven PM, Umman S, Knaapen P, Perera D, Akasaka T, Sezer M, Kharbanda RK, van Royen N. Hyperaemic mi-crovascular resistance predicts clinical outcome and microvascular injury after myocardial infarction. Heart. 2017. Impact Factor 6.059

29. Dobson LE, Musa TA, Uddin A, Fairbairn TA, Bebb OJ, Swoboda PP, Haaf P, Foley J, Garg P, Fent GJ, Malkin CJ, Blackman DJ, Plein S, Greenwood JP. The impact of trans-catheter aortic valve replace-ment induced left-bundle branch block on cardiac reverse remodel-ling. J Cardiovasc Magn Reson. Impact Factor 5.601

30. Faggioni M, Baber U, Afshar AE, Giustino G, Sartori S, Sorren-tino S, Steg PG, Stefanini GG, Windecker S, Leon MB, Stone GW, Wijns W, Serruys PW, Valgimigli M, Camenzind E, Weisz G, Smits PC, Kandzari DE, Galatius S, Von Birgelen C, Jeger RV, Mikhail GW, Itchhaporia D, Mehta L, Ortega R, Kim HS, Kastrati A, Chieffo A, Dangas GD, Morice MC, Mehran R. Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Pa-tient-Level Pooled Analysis of Randomized Controlled Trials. JACC Cardiovasc Interv. 2017. Impact Factor 8.841

46

45. Hengstenberg C, Chandrasekhar J, Sartori S, Lefevre T, Mik-hail G, Meneveau N, Tron C, Jeger R, Kupatt C, Vogel B, Farhan S, Sorrentino S, Sharma M, Snyder C, Husser O, Boekstegers P, Hambrecht R, Widder J, Hildick-Smith D, De Carlo M, Wijngaard P, Deliargyris E, Bernstein D, Baber U, Mehran R, Anthopoulos P, Dan-gas G; BRAVO-3 Investigators. Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial. Catheter Cardiovasc Interv. 2017. Impact Factor 2.602

46. Herrero-Puente P, Prieto-Garc“a B, García-Garc“a M, Llorens P, Mart“n-S‡nchez FJ, Jacob J, Mebazaa A, Mueller C, Maisel AS, Gil V, Garc“a-Hernandez P, Mir— ñ. The relationship of circulating re-laxin-2 concentrations with short-term prognosis in patients with acute heart failure. The RELAHF study. Eur J Heart Fail 2017 [Epub ahead of print]. Impact Factor 6.968

47. Hillinger P, Twerenbold R, Wildi K, Rubini Gimenez M, Jaeger C, Boeddinghaus J, Nestelberger T, Grimm K, Reichlin T, Stallone F, Pu-elacher C, Sabti Z, Kozhuharov N, Honegger U, Ballarino P, Miro O, Denhaerynck K, Ekrem T, Kohler C, Bingisser R, Osswald S, Mueller C.Gender-specific Uncertainties in the Diagnosis of Acute Coronary Syndrome. Clin Res Cardiol 2017. Impact factor 4.8

48. Iglesias JF, Muller O, Zaugg S, Roffi M, Kurz DJ, Vuilliomenet A, Weilenmann D, Kaiser C, Tapponnier M, Heg D, Valgimigli M, Eeck-hout E, JŸni P, Windecker S, Pilgrim T. A comparison of an ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute stsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial. Eurointervention 2017. Impact Factor 5.165

49. Jacob J, Roset A, Mir— ñ, Alqu�zar A, Herrero P, Mart’n-San-chez FJ, Mšckel M, MŸller C, Llorens P. TROPICA-2 Study. Prog-nostic value of troponin in patients with acute heart failure treated in Spanish hospital emergency services. Biomarkers 2017. Impact Factor 2.016

50. Jatene T, Biering-S¿rensen T, Nochioka K, Mangione FM, Han-sen KW, S¿rensen R, Jensen JS, J¿rgensen PG, Jeger R, Kaiser C, Pfisterer M, Galatius S; BASKET-PROVE Investigators. Frequency of Cardiac Death and Stent Thrombosis in Patients With Chronic Ob-structive Pulmonary Disease Undergoing Percutaneous Coronary Intervention (from the BASKET-PROVE I and II Trials). Am J Cardiol 2017. Impact Factor 3.398

38. Gayat E, Arrigo M, Littnerova S, Sato N, Parenica J, Ishihara S, Spinar J, MŸller C, Harjola VP, Lassus J, Mir— ñ, Maggioni AP, AlHabib KF, Choi DJ, Park JJ, Zhang Y, Zhang J, Januzzi JL Jr, Kaji-moto K, Cohen-Solal A, Mebazaa A; GREAT Network. Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study. Eur J Heart Fail 2017. Impact Factor 6.968

39. Giustino G, Harari R, Baber U, Sartori S, Stone GW, Leon MB, Windecker S, Serruys PW, Kastrati A, Von Birgelen C, Kimura T, Ste-fanini GG, Dangas GD, Wijns W, Steg PG, Morice MC, Camenzind E, Weisz G, Smits PC, Sorrentino S, Sharma M, Farhan S, Faggioni M, Kandzari D, Galatius S, Jeger RV, Valgimigli M, Itchhaporia D, Mehta L, Kim HS, Chieffo A, Mehran R. Long-term Safety and Effi-cacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. JAMA Cardiol. 2017

40. Grapow M, Haug M, Tschung C, Winkler B, Banerjee P, Heinisch PP, Fassl J, Reuthebuch O, Eckstein F. Therapy options in deep ster-nal wound infection: Sternal plating versus muscle flap. PLoS One. 2017. Impact Factor 2.806

41. Greenslade JH, Adikari T, Mueller C, Sandoval Y, Nestelberger T, Parsonage W, Hawkins T, Cullen L. Characteristics and occurrence of type 2 myocardial infarction in emergency department patients: a prospective study. Emerg Med J. 2017. Impact Factor 1.861

42. Gualandro DM, Puelacher C, Lurati Buse G, Llobet GB, Yu PC, Cardozo FA, Glarner N, Zimmerli A, Espinola J, Corbi�re S, Caldera-ro D, Marques AC, Casella IB, de Luccia N, Oliveira MT, Lampart A, Bolliger D, Steiner L, Seeberger M, Kindler C, Osswald S, Gürke L, Caramelli B, Mueller C; GREAT network. Prediction of major cardiac events after vascular surgery. J Vasc Surg. 2017. Impact Factor 3.545

43. GŸnther F, Heidt T, Kramer M, Khanicheh E, Klibanov AL, Geibel-Zehender A, Ferrante EA, Hilgendorf I, Wolf D, Zirlik A, Reinšhl J, Bode C, Peter K, Kaufmann BA*, MŸhlen CVZ*. Dual targeting im-proves capture of ultrasound microbubbles towards activated pla-telets but yields no additional benefit for imaging of arterial throm-bosis. Sci Rep. 2017. Impact Factor 4.259

44. Haaf P, Ritter M, Grize L, Pfisterer ME, Zellweger MJ; BARDOT study group. Quality of life as predictor for the development of car-diac ischemia in high-risk asymptomatic diabetic patients. J Nucl Cardiol. 2017. Impact Factor 3.930

47

Publikationen

10 Publikationen

59. Koskinas KC, Taniwaki M, Rigamonti F, Heg D, Roffi M, TŸller D, Muller O, Vuillomenet A, Cook S, Weilenmann D, Kaiser C, Jams-hidi P, JŸni P, Windecker S, Pilgrim T. Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascu-larization With New-Generation Drug-Eluting Stents. Am J Cardiol. 2017. Impact Factor 3.398

60. Krivoshei L, Weber S, Burkard T, Maseli A, Brasier N, KŸhne M, Conen D, Huebner T, Seeck A and Eckstein J. Smart detection of atrial fibrillation. Europace. 2017. Impact Factor 4.530

61. Laribi S, Pemberton CJ, Kirwan L, Nouira S, Turkdogan K, Yilmaz MB, Troughton RW, Gayat E, Rivas-Lasarte M, Sadoune M, Sabti Z, Hansconrad E, Motiejunaite J, Plaisance P, Beshiri A, Chen W, Collet C, FitzGerald JM, Mueller C, Launay JM, Richards M, Me-bazaa A; GREAT (Global Research on Acute Conditions Team) Net-work. Mortality and acute exacerbation of COPD: a pilot study on the influence of myocardial injury. Eur Respir J. 2017. Impact Factor 10.569

62. Legrand M, Ludes PO, Massy Z, Rossignol P, Parenica J, Park JJ, Ishihara S, AlHabib KF, Maggioni A, Mir— ñ, Sato N, Cohen-Solal A, Fairman E, Lassus J, Harjola VP, Mueller C, Peacock FW, Choi DJ, Plaisance P, Spinar J, Kosiborod M, Mebazaa A, Gayat E; GREAT (Global Research on Acute Conditions Team) Network and INI-CRCT (Investigation Network Initiative-Cardiovascular and Re-nal Clinical Trialists) network. Association between hypo- and hy-perkalemia and outcome in acute heart failure patients: the role of medications. Clin Res Cardiol. 2017 [Epub ahead of print]. Impact Factor 4.760

63. Lindahl B, Jernberg T, Badertscher P, Boeddinghaus J, Eggers KM, Frick M, Rubini Gimenez M, Linder R, Ljung L, Martinsson A, Melki D, Nestelberger T, Rentsch K, Reichlin T, Sabti Z, Schubera M, Svensson P, Twerenbold R, Wildi K, Mueller C. An algorithm for rule-in and rule-out of acute myocardial infarction using a novel Troponin I assay. Heart 2017. Impact Factor 6.059

64. Liu D, Borlotti A, Viliani D, Jerosch-Herold M, Alkhalil M, De Maria GL, Fahrni G, Dawkins S, Wijesurendra R, Francis J, Ferreira V, Piechnik S, Robson MD, Banning A, Choudhury R, Neubauer S, Channon K, Kharbanda R, Dall'Armellina E. CMR Native T1 Map-ping Allows Differentiation of Reversible Versus Irreversible Myo-cardial Damage in ST-Segment-Elevation Myocardial Infarction: An OxAMI Study (Oxford Acute Myocardial Infarction). Circ Cardiovasc Imaging. 2017. Impact Factor 6.803

51. Jeger JR, Pfister O, Radovanovic D, Eberli FR, Rickli H, Urban P, Pedrazzini G, Stauffer JC, Nossen J, Erne P, for the AMIS-Plus Inves-tigators (*joint first authorship). Heart failure in patients admitted for acute coronary syndromes: A report from a large national registry. Clin Cardiol. 2017. Impact Factor 2.757

52. Jekova I, Krasteva V, Leber R, Schmid R, Twerenbold R, MŸller C, Reichlin T, AbŠcherli R. A Correction Formula for the ST Segment Measurements for the AC-coupled Electrocardiograms. IEEE Tran-sactions on Biomedical Engineering 2017. Impact Factor 1,29.

53. Jekova I, Krasteva V, Leber R, Schmid R, Twerenbold R, MŸller C, Reichlin T, AbŠcherli R. IBiomedical Signal Processing and Con-trol 2017; in press. Impact Factor 1.521.

54. Kaier TE, Twerenbold R, Puelacher C, Marjot J, Imambaccus N, Boeddinghaus J, Nestelberger T, Badertscher P, Sabti Z, Gim�nez MR, Wildi K, Hillinger P, Grimm K, Loeffel S, Shrestha S, Widmer DF, Cupa J, Kozhuharov N, Mir— ñ, Mart’n-S‡nchez FJ, Morawiec B, Rentsch K, Lohrmann J, Kloos W, Osswald S, Reichlin T, Weber E, Marber M, Mueller C. Direct comparison of cardiac myosin-binding protein C to cardiac troponins for the early diagnosis of acute myo-cardial infarction. Circulation 2017. Impact Factor 19.309

55. Knecht S, Burch F, Reichlin T, Spies F, MŸhl A, Altmann D, Am-mann P, Schaer B, Osswald S, Sticherling C, KŸhne M. First clini-cal experience of a dedicated irrigated-tip radiofrequency ablation catheter for the ablation of cavotricuspid isthmus-dependent atrial flutter. Clin Res Cardiol 2017. Impact Factor 4.760

56. Knecht S, Pradella M, Reichlin T, MŸhl A, Bossard M, Stieltjes B, Conen D, Bremerich J, Osswald S, KŸhne M, Sticherling C. Left at-rial anatomy, atrial fibrillation burden and P-wave duration - relation-ships and predictors for single procedure success after pulmonary vein isolation. Europace 2017. Impact Factor 4.521

57. Knecht S, Sticherling C, Reichlin T, MŸhl A, Pavlovic N, Schaer B, Osswald S, KŸhne M. Reliability of luminal oesophageal temperature monitoring during radiofrequency ablation of atrial fibrillation: insights from probe visualization and oesophageal reconstruction using mag-netic resonance imaging. Europace 2017. Impact Factor 4.521

58. Kofler T, Th�riault S, Bossard M, Aeschbacher S, Bernet S, Krisai P, Blum S, Risch M, Risch L, Albert CM, Par� G, Conen D. Relati-onships of Measured and Genetically Determined Height With the Cardiac Conduction System in Healthy Adults. Circ Arrhythm Elec-trophysiol, 2017. Impact Factor

48

65. Maier A, Plaza-Heck P, Meixner F, Guenther F, Kaufmann BA, Kramer M, Heidt T, Zirlik A, Hilgendorf I, Reinšhl J, Stachon P, Bron-sert P, Birkemeyer R, Neudorfer I, Peter K, Bode C, von Zur MŸhlen C. A molecular intravascular ultrasound contrast agent allows de-tection of activated platelets on the surface of symptomatic human plaques. Atherosclerosis. 2017. Impact factor 4.239

66. Maseli A, Aeschbacher S, Schoen T, Fischer A, Jung M, Risch M, Risch L, Conen D. Healthy Lifestyle and Blood Pressure Variabili-ty in Young Adults. Am J Hypertens, 2017. Impact Factor

67. Mangione FM, Biering-S¿rensen T, Nochioka K, Jatene T, Sil-vestre OM, Hansen KW, S¿rensen R, Jensen JS, Jorgensen PG, Jeger R, Kaiser C, Pfisterer M, Galatius S. Second generation drug-eluting stents versus bare-metal stents for percutaneous corona-ry intervention of the proximal left anterior descending artery: An analysis of the BASKET-PROVE I and II trials. Catheter Cardiovasc Interv. 2017. [Epub ahead of print] Impact Factor 2.602

68. Mart’n-S‡nchez FJ, Rodr’guez-Adrada E, Mueller C, Vid‡n MT, Christ M, Peacock WF, Rizzi MA, Alquezar A, Pi–era P, Lˆzaro Aragues P, Llorens P, Herrero P, Jacob J, Fern‡ndez C, Mir— ñ. The effect of frailty on 30-day mortality risk in older patients with acute heart failure attended in the Emergency Department. Acad Emerg Med J. 2017. Impact Factor 1.861

69. Matt P, Banerjee P, Grapow M, Rueter F, Schurr U, Siegemund M, Fassl J, Reuthebuch O, Eckstein F. Modified frozen elephant trunk for acute type A aortic dissection: a comparative study with standard repair technique. Eur J Cardiothorac Surg. 2017. Impact Factor 3.759

70. Mueller-Hennessen M, Mueller C, Giannitsis E, Biener M, Vafaie M, deFilippi CR, Christ M, Ord—–ez-Llanos J, Panteghini M, Plebani M, Verschuren F, Melki D, French JK, Christenson RH, Body R, Mc-Cord J, Dinkel C, Katus HA, Lindahl B for the TRAPID-AMI Investi-gators. Serial Sampling of High-Sensitivity Cardiac Troponin T May Not Be Required for Prediction of Acute Myocardial Infarction Dia-gnosis in Chest Pain Patients with Highly Abnormal Concentrations at Presentation. Clin Chemistry 2017. Impact Factor 8.008

71. McCord J, Cabrera R, Lindahl B, Giannitsis E, Evans K, Nowak R, Frisoli T, Body R, Christ M, deFilippi CR, Christenson RH, Jacob-sen G, Alquezar A, Panteghini M, Melki D, Plebani M, Verschuren F, French J, Bendig G, Weiser S, Mueller C; TRAPID-AMI Investiga-torsPrognostic Utility of a Modified HEART Score in Acute Chest Pain Patients. Circulation: Cardiovascular Quality & Outcomes 2017. Impact Factor 4.282

72. Mir— ñ, Gonz‡lez de la Presa B B, Herrero P, Fern‡ndez Boni-facio R, Mšckel M, Mueller C, Casals G, Sandalinas S, Llorens P, Mart’n-S‡nchez FJ, Jacob J, Bedini JL, Gil V. The GALA study: Rela-tionship between galectin-3 serum levels and short- and long-term outcomes of patients with acute heart failure. Biomarkers 2017. [Epub ahead of print]. Impact Factor 2.016

73. Mochizuki M, Lorenz V, Ivanek R, Della Verde G, Gaudiello E, Marsano A, Pfister O, Kuster GM. Polo-like kinase 2 is dynamically regulated to coordinate proliferation and early lineage specification downstream of yes-associated protein 1 in cardiac progenitor cells. J Am Heart Assoc. 2017. Impact Factor 5.117

74. Musa TA, Uddin A, Swoboda PP, Fairbairn TA, Dobson LE, Singh A, Garg P, Steadman CD, Erhayiem B, Kidambi A, Ripley DP, McDi-armid AK, Haaf P, Blackman DJ, Plein S, McCann GP, Greenwood JP. Cardiovascular magnetic resonance evaluation of symptomatic severe aortic stenosis: association of circumferential myocardial strain and mortality. J Cardiovasc Magn Reson. 2017. Impact Fac-tor 5.601

75. Nazerian P, Mueller C, de Matos Soeiro A, Leidel BA, Salvadeo SAT, Giachino F, Vanni S, Grimm K, Oliveira MT Jr, Pivetta EE, Lupia E, Grifoni S, Morello F; ADvISED Investigators. Diagnostic Accuracy of the Aortic Dissection Detection Risk Score Plus D-Dimer for Acu-te Aortic Syndromes: The ADvISED Prospective Multicenter Study. Circulation. Impact Factor 19.309

76. Nestelberger T, Boeddinghaus J, Badertscher P, Twerenbold R, Wildi K, BreitenbŸcher D, Sabti Z, Puelacher C, Rubini Gim�nez M, Kozhuharov N, Strebel I, Sazgary L, Schneider D, Jann J, du Fay de Lavallaz J, Mir— ñ, Martin-Sanchez FJ, Morawiec B, Kawecki D, Mu-zyk P, Keller DI, Geigy N, Osswald S, Reichlin T, Mueller C; APACE Investigators. Effect of Definition on Incidence and Prognosis of Type 2 Myocardial Infarction Journal of the American College of Cardiology 2017. Impact Factor 19.896

77. Ng LL, Squire IB, Jones DJ, Cao TH, Chan DC, Sandhu JK, Quinn PA, Davies JE, Struck J, Hartmann O, Bergmann A, Mebazaa A, Gayat E, Arrigo M, Akiyama E, Sabti Z, Lohrmann J, Twerenbold R, Herrmann T, Schumacher C, Kozhuharov N, Mueller C. Proenke-phalin, prediction of renal dysfunction and short and longer term prognosis in acute heart failure - a GREAT network study. J Am Coll Cardiol 2017. Impact Factor 19.896

49

Publikationen

10 Publikationen

84. Puelacher C, Lurati Buse G, Seeberger D, Sazgary L, Marbot S, Lampart A, Espinola J, Kindler C, Hammerer A, Seeberger E, Stre-bel I, Wildi K, Twerenbold R, du Fay de Lavallaz J, Steiner L, Gurke L, Breidthardt T, Rentsch K, Buser A, Gualandro DM, Osswald S, Mueller C, for the BASEL-PMI Investigators. Perioperative myocar-dial injury after non-cardiac surgery: incidence, mortality and cha-racterization. Circulation 2017. [Epub ahead of print.] Impact Factor 19.309

85. Puelacher C, Wagener M, AbŠcherli R, Honegger U, Lhasam N, Schaerli N, Pr�tre G, Strebel I, Twerenbold R, Boeddinghaus J, Nestelberger T, Rubini Gim�nez M, Hillinger P, Wildi K, Sabti Z, Ba-dertscher P, Cupa J, Kozhuharov N, du Fay de Lavallaz J, Freese M, Roux I, Lohrmann J, Leber R, Osswald S, Wild D, Zellweger MJ, Mueller C, Reichlin T. Diagnostic value of ST-segment deviations during cardiac exercise stress testing: Systematic comparison of different ECG leads and time-points. Int J Cardiol 2017. Impact Fac-tor 6.189

86. Puelacher C, Wagener M, Honegger U, Assadian M, Schaerli N, Mueller D, Strebel I, Twerenbold R, Boeddinghaus J, Nestelberger T, Wildi K, Sabti Z, Sazgary L, Badertscher P, du Fay de Lavallaz J, Marbot S, Kaiser C, Wild D, Zellweger MJ, Reichlin T, Mueller C. Combining high-sensitivity cardiac troponin and B-type natriuretic peptide in the detection of inducible myocardial ischemia. Clin Bio-chem. 2017. Impact Factor 2.434.

87. Remy MM, Sahin M, Flatz L, Regen T, Xu L, Kreutzfeldt M, Fal-let B, Doras C, Rieger T, Bestmann L, Hanisch UK, Kaufmann BA, Merkler D, Pinschewer DD. Interferon'Driven iNOS: A Molecular Pathway to Terminal Shock in Arenavirus Hemorrhagic Fever. Cell Host Microbe. 2017. Impact Factor 14.946.

88. Reusser A, Blum S, Aeschbacher S, Eggimann L, Ammann P, Erne P, Moschovitis G, Di Valentino M, Shah D, SchlŠpfer J, Manser S, Reichlin T, KŸhne M, Sticherling C, Osswald S, Conen D. QTc interval, cardiovascular events and mortality in patients with atrial fibrillation. Int J Cardiol 2018, Epub 2017. Impact Factor 6.189

89. Rickenbacher P, Kaufmann BA, Maeder MT, Bernheim A, Goe-tschalckx K, Pfister O, Pfisterer M, Brunner-La Rocca HP; TIME-CHF Investigators. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF). Eur J Heart Fail. 2017. Impact Factor 6.968.

78. Noble S, Stortecky S, Heg D, Tueller D, Jeger R, Toggweiler S, Ferrari E, Nietlispach F, Taramasso M, Maisano F, GrŸnenfelder J, JŸni P, Huber C, Carrel T, Windecker S, Wenaweser P, Roffi M. Com-parison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis. EuroInterven-tion. 2017. Impact Factor 5.165

79. Nochioka K, Biering-S¿rensen T, Hansen KW, S¿rensen R, Pe-dersen S, J¿rgensen PG, Iversen A, Shimokawa H, Jeger R, Kaiser C, Pfisterer M, Galatius S; BASKET-PROVE Investigators. Long-term outcomes in patients with rheumatologic disorders undergoing per-cutaneous coronary intervention: a BAsel Stent Kosten-EffektivitŠts Trial-PROspective Validation Examination (BASKET-PROVE) sub-study. Eur Heart J Acute Cardiovasc Care. 2017

80. Nowak R, Mueller C, Giannitsis E, Christ M, Ordonez-Llanos J, DeFilippi C, McCord J, Body R, Panteghini M, Jernberg T, Plebani M, Verschuren F, French J, Christenson, Jacobsen G, Dinkel C, Lin-dahl B.. High sensitivity cardiac troponin T in patients not having an acute coronary syndrome: Results from the TRAPID-AMI study. Biomarkers 2017. Impact Factor 2.006

81. Pedrazzini GB, Ferrari E, Zellweger M, Genoni M. Heart Team: Joint Position of the Swiss Society of Cardiology and the Swiss Society of Cardiac Surgery. Thorac Cardiovasc Surg. 2017. Impact Factor 4.446

82. Pickering JW, Than MP, Cullen L, Aldous S, Ter Avest E, Body R, Carlton EW, Collinson P, Dupuy AM, Ekelund U, Eggers KM, Flor-kowski CM, Freund Y, George P, Goodacre S, Greenslade JH, Jaffe AS, Lord SJ, Mokhtari A, Mueller C, Munro A, Mustapha S, Parso-nage W, Peacock WF, Pemberton C, Richards AM, Sanchis J, Staub LP, Troughton R, Twerenbold R, Wildi K, Young J. Rapid Rule-out of Myocardial Infarction with a High-sensitivity Cardiac Troponin T measurement below the limit of detection: A collaborative meta-analysis. Ann Intern Med 2017. [Epub ahead of print]. Impact Factor 17.135

83. Pilgrim T, Franzone A, Stortecky S, Nietlispach F, Haynes AG, Tu-eller D, Toggweiler S, Muller O, Ferrari E, Noble S, Maisano F, Jeger R, Roffi M, GrŸnenfelder J, Huber C, Wenaweser P, Windecker S. Predicting Mortality After Transcatheter Aortic Valve Replacement: External Validation of the Transcatheter Valve Therapy Registry Mo-del. Circ Cardiovasc Interv. 2017. Impact Factor 7.198

50

90. Rigamonti F, Fahrni G, Maeder M, Cook S, Weilenmann D, Wenaweser P, Ršthlisberger C, Corti R, Rickli H, Kaiser C, Roffi M. Switzerland: coronary and structural heart interventions from 2010 to 2015. EuroIntervention. 2017. Impact Factor 5.165

91. Schoen T, Aeschbacher S, Leuppi JD, Miedinger D, WerthmŸller U, Estis J, Todd J, Risch M, Risch L, Conen D. Subclinical sleep apnoea and plasma levels of endothelin-1 among young and healthy adults. Open Heart 2017. Impact Factor

92. Shahinian JH, Mayer B, Tholen S, Brehm K, Biniossek ML, FŸllgraf H, Kiefer S, Heizmann U, Heilmann C, RŸter F, Grapow M, Reuthebuch OT, Eckstein F, Beyersdorf F, Schilling O, Siepe M. Pro-teomics highlights decrease of matricellular proteins in left ventri-cular assist device therapy. Eur J Cardiothorac Surg. 2017. Impact Factor 1.101

93. Spies F, KŸhne M, Reichlin T, Osswald S, Sticherling C, Knecht S. A quantitative comparison of the electrical and anatomical de-finition of the pulmonary vein ostium. Pacing Clin Electrophysiol. 2017. Impact Factor 1.486

94. Sticherling C, Arendacka B, Hastrup Svendsen J, Wijers S, Frie-de T, Stockinger J, Dommasch M, Merkely B, Willems R, Lubinski A, Scharfe M, Braunschweig F, Svetlosak M, ZŸrn CS, Huikuri H, Flevari P, Lund-Andersen C, Schaer BA, Tuinenburg AE, Bergau L, Schmidt G, Szeplaki G, Vanderberk B, Kowalczyk E, Eick C, Juntilla J, Conen D, Zabel M for the EU-CERT ICD investigators. Sex diffe-rences in outcomes of primary prevention ICD therapy: combined registry data from eleven European countries. Europace 2017. Impact Factor 4.530

95. Stauber A, Wey C, Greutmann M, Tobler D, Wustmann K, Wahl A, Valsangiacomo Buechel ER, Wilhelm M, Schwerzmann M. Left ventricular outflow tract obstruction and its impact on systolic ven-tricular function and exercise capacity in adults with a subaortic right ventricle. Int J Cardiol. 2017. Impact Factor 6.189

96. Staubli SM, Cerino G, Gonzalez De Torre I, Alonso M, Oertli D, Eckstein F, Glatz K, Rodríguez Cabello JC, Marsano A. Control of angiogenesis and host response by modulating the cell adhesion properties of an Elastin-Like Recombinamer-based hydrogel. Bio-materials. 2017;135:30-41. Impact factor 8.401

97. Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Savonitto S, Torremante P, Vrints C, Schneider S, Desch S, Zeymer U; CULPRIT-SHOCK Investigators (Jeger R Collaborator). PCI Stra-tegies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. N Engl J Med. 2017. Impact Factor 72.406

98. Tobler D, Bouchardy J, Reto E, Heg D, MŸller C, Frenk A, Gabriel H, Schwitter J, Rutz T, Buechel RR, Willhelm M, Trachsel L, Freese M, Greutmann M, Schwerzmann M; SERVE trial. Effect of phos-phodiesterase-5 inhibition with Tadalafil on SystEmic Right VEntri-cular size and function - A multi-center, double-blind, randomized, placebo-controlled clinical trial - SERVE trial - Rational and design. Int J Cardiol. 2017. Impact Factor 6.189

99. Tobler D, Schwerzmann M, Bouchardy J, Engel R, Stambach D, Attenhofer Jost C, Wustmann K, Schwitz F, Rutz T, Gabriel H, Kuen HP, Auf der Maur C, Oxenius A, Seeliger T, Santos Lopes B, Bonassin F, Greutmann M. Swiss Adult Congenital Heart disease Registry (SACHER) - rationale, design and first results. Swiss Med Wkly. 2017. Impact Factor 1.654

100. Toma A, StŠhli BE, Gick M, Gebhard C, Kaufmann BA, Mas-hayekhi K, Ferenc M, Buettner HJ, Neumann FJ. Comparison of Be-nefit of Successful Percutaneous Coronary Intervention for Chronic Total Occlusion in Patients With Versus Without Reduced (≤40%) Left Ventricular Ejection Fraction. Am J Cardiol. 2017. Impact Fac-tor 3.398

101. Twerenbold R, Badertscher P, Boeddinghaus J, Nestelberger T, Wildi K, Puelacher C, Sabti Z, Rubini Gimenez M, Tschirky S, du Fay de Lavallaz J, Kozhuharov N, Sazgary L, Mueller D, Breidthardt T, Strebel I, Flores Widmer D, Shrestha S, Mir— ñ, Martín-S‡nchez FJ, Morawiec B, Parenica J, Geigy N, Keller DI, Rentsch K, von Eckard-stein A, Osswald S, Reichlin T, Mueller C. 0/1-Hour Triage Algorithm for Myocardial Infarction in Patients with Renal Dysfunction. Circu-lation 2017. Impact Factor 19.309

102. Twerenbold R, Badertscher P, Boeddinghaus J, Nestelberger T, Wildi K, Rubini Gimenez M, Mir— ñ, Martín-S‡nchez FJ, Reichlin T, Mueller C. Effect of the FDA Regulatory Approach on the 0/1-h Al-gorithm for Rapid Diagnosis of MI. Journal of the American College of Cardiology 2017. Impact Factor 19.896

51

Publikationen

10 Publikationen

110. Wildi K, Cullen L, Twerenbold R, Greenslade JH, Parsonage W, Boeddinghaus J, Nestelberger T, Sabti Z, Rubini-Gim�nez M, Puela-cher C, Cupa J, Schumacher L, Badertscher P, Grimm K, Kozhuha-rov N, Stelzig C, Freese M, Rentsch K, Lohrmann J, Kloos W, Buser A, Reichlin T, Pickering JW, Than M, Mueller C. Direct Comparison of two Rule-out Strategies for Acute Myocardial Infarction: 2h-Ac-celerated Diagnostic Protocol versus 2h-Algorithm. Clin Chemistry 2017. Impact Factor 8.008

111. Yang H, Bouma BJ, Mulder BJM. Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease? Cardio-vasc Drugs Ther. 2017. Impact Factor 2.820

112. Zbinden R, von Felten S, Wein B, Tueller D, Kurz DJ, Reho I, Galatius S, Alber H, Conen D, Pfisterer M, Kaiser C, Eberli FR. Im-pact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents - a clinical and health-economic evaluation. Cardiovasc Ther. 2017. Im-pact Factor 2.478

113. Zellweger MJ, Haaf P, Maraun M, Osterhues HH, Keller U, MŸller-Brand J, Jeger R, Pfister O, Brinkert M, Burkard T, Pfisterer M; BARDOT Investigators. Predictors and prognostic impact of si-lent coronary artery disease in asymptomatic high-risk patients with diabetes mellitus. Int J Cardiol. 2017. Impact Factor 6.189

114. Zimny M, Blum S, Ammann P, Erne P, Moschovitis G, Di Valen-tino M, Shah D, SchlŠpfer J, Vogt C, Tabord A, KŸhne M, Sticherling C, Osswald S, Conen D. Uptake of non-vitamin K antagonist oral anti coagulants in patients with atrial fibrillation - a prospective co-hort study. Swiss Med Wkly 2017. Impact Factor 1.654

Reviews

1. Celikyurt I, Meier CR, KŸhne M, Schaer B. Safety and interactions of direct oral anticoagulants with antiarrhythmic drugs. Drug Saf 2017. Impact Factor 3.439

2. Garg P, Morris P, Fazlanie AL, Vijayan S, Dancso B, Dastidar AG, Plein S, Mueller C, Haaf P. Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin. Intern Emerg Med. 2017. Epub 2017. Review. Impact Factor 2.340

103. Van der Linden N, Cornelis T, Kimenai DM, Klinkenberg LJJ, Hilderink JM, LŸck S, Litjens EJR, Peeters FECM, Streng AS, Breidthardt T, van Loon LJC, Bekers O, Kooman JP, Westermark PO, Mueller C, Meex SJR.The Origin of Cardiac Troponin T Elevations in Chronic Kidney Disease. Circulation 2017. Impact Factor 19.309

104. Vischer AS, Winterhalder C, Leonardi L, Maseli A, Eckstein J, Burkard T. Is office blood pressure measurement reliable for in-dividual decision making? � Rsultes of the iPARR trial. Journal of Hypertension 2017. Impact Factor 4.085

105. Vischer AS and Burkard T. Principles of Blood Pressure Measu-rement - Current Techniques, Office vs Ambulatory Blood Pressure Measurement. Adv Exp Med Biol. 2017. Impact Factor 1.881

106. Wagener M, AbŠcherli R, Honegger U, Schaerli N, Pr�tre G, Twerenbold R, Puelacher C, Sunier G, Reddiess P, Rubini Gimenez M, Wildi K, Boeddinghaus J, Nestelberger T, Badertscher P, Sab-ti Z, Schmid R, Leber R, Widmer DF, Shrestha S, Strebel I, Wild D, Osswald S, Zellweger M, Mueller C, Reichlin T. Diagnostic and prognostic value of lead aVR during exercise testing in patients su-spected of having myocardial ischemia. Am J Cardiol 2017. Impact Factor 3.398

107. Walter JE, Honegger U, Puelacher C, Mueller D, Wagener M, Schaerli N, Strebel I, Twerenbold R, Boeddinghaus J, Nestelberger T, Sazgary L, Marbot S, de Lavallaz JDF, Kaiser C, Osswald S, Wild D, Rentsch K, Zellweger M, Reichlin T, Mueller C. Prospective Validati-on of a Biomarker-Based Rule Out Strategy for Functionally Relevant Coronary Artery Disease. Clin Chem. 2017. Impact Factor 8.008

108. Wein B, Coslovsky M, Jabbari R, Galatius S, Pfisterer M, Kaiser C. Prasugrel vs. clopidogrel in contemporary Western European pa-tients with acute coronary syndromes receiving drug-eluting stents: Comparative cost-effectiveness analysis from the BASKET-PROVE cohorts. Int J Cardiol. 2017. Impact Factor 6.189

109. Wienbergen H, Pfister O, Hochadel M, Michel S, Bruder O, Remppis BA, Maeder MT, Strasser R, von Scheidt W, Pauschinger M, Senges J, Hambrecht R; RAID-HF (Registry Analysis of Iron De-ficiency–Heart Failure) REGISTRY Study Group (*joint first author-ship). Usefulness of iron deficiency correction in management of patients with heart failure (from the Registry Analysis of Iron Devi-ciency-Heart Failure (RAID-HF) Registry. Am J Cardiol. 2016 Impact Factor 3.398

52

3. Gorenek B, Bax J, Boriani G, Chen SA, Dagres N, Glotzer TV, Healey JS, Israel CW, Kudaiberdieva G, Levin L�, Lip GYH, Martin D, Okumura K, Svendsen JH, Tse HF, Botto GL; Document Review-ers: Sticherling C (Reviewer Coordinator), Linde C, Kutyifa V, Bernat R, Scherr D, Lau CP, Iturralde P, P Morin D, Savelieva I. Device-detected subclinical atrial tachyarrhythmis: definition, implications and management � an European Heart Rhythm Association (EHRA) consensus document. Europace 2017. Impact Factor 4.210

4. Harjola VP, Mullens W, Banaszewski M, Bauersachs J, Brunner-La Rocca HP, Chioncel O, Collins SP, Doehner W, Filippatos GS, Flammer AJ, Fuhrmann V, Lainscak M, Lassus J, Legrand M, Masip J, Mueller C, Papp Z, Parissis J, Platz E, Rudiger A, Ruschitzka F, SchŠfer A, Seferovic PM, Skouri H, Yilmaz MB, Mebazaa A. Organ dysfunction, injury and failure in acute heart failure: from patho-physiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2017. Impact Factor 6.968

5. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimsk� P; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myo-cardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2017 [Epub ahead of print] Impact Factor 19.651

6. Lip GYH, Collet JP, Caterina R, Fauchier L, Lane DA, Larsen TB, Marin F, Morais J, Narasimhan C, Olshansky B, Pierard L, Potpara T, Sarrafzadegan N, Sliwa K, Varela G, Vilahur G, Weiss T, Boriani G, Rocca B, Gorenek B, Savelieva I, Sticherling C, Kudaiberdieva G, Chao TF, Violi F, Nair M, Zimerman L, Piccini J, Storey R, Halvorsen S, Gorog D, Rubboli A, Chin A, Scott-Millar R. Antithrombotic thera-py in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Associati-on (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Socie-dad Latinoamericana de Estimulaci—n Cardíaca y Electrofisiolog’a (SOLEACE) Europace 2017. Impact Factor 4.530

7. Mair J, Lindahl B, Giannitsis E, Huber K, Thygesen K, Plebani M, Mšckel M, MŸller C, Jaffe AS; Biomarker Study Group of the European Society of Cardiology Acute Cardiovascular Care Association. Will sa-cubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care? Eur Heart J Acute Cardiovasc Care. 2017.

8. Mair J, Lindahl B, MŸller C, Giannitsis E, Huber K, Mšckel M, Plebani M, Thygesen K, Jaffe AS; Biomarker Study Group of the European Society of Cardiology Acute Cardiovascular Care Associ-ation. What to do when you question cardiac troponin values? Eur Heart J Acute Cardiovasc Care. 2017.

9. Mair J, Lindahl B, MŸller C, Giannitsis E, Huber K, Mšckel M, Plebani M, Thygesen K, Jaffe AS. What to do when you question cardiac troponin values. Eur Heart J Acute Cardiovasc Care. 2017

10. Mairesse GH, Moran P, Van Gelder IC, Elsner C, Rosenqvist M, Mant J, Banerjee A, Gorenek B, Brachmann J, Varman N, Glotz de Lima G, Kalman J, Claes N, Lobban T, Lane D, Lip GYH, Boriani G; Collaborators: Fauchier L, Jung W, Savelieva I, Freedman B, Chen SA, Isa R, Turakhia M, Sapp JL, Lip G, Gorenek B, Sticherling C, Fachier L, Goette A, Jung W, Vos MA, Brignole M, Elsner C, Dan GA, Marin F, Boriani G, Lane D, Lundqvist CB, Savelieva I. Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulaci—n Cardíaca y Electrofisiología (SOLAECE). Europace. Impact Factor 4.521

11. Miro O, Peacock FW, Christ M, Cowie M, Cullen L, Maisel AS, Masip J, Miro O, McMurray J, Peacock FW, Price S, DiSomma S, Bueno H, Zeymer U, Mebazaa A, Mueller C. European Society of Car-diology - Acute Cardiovascular Care Association position paper on safe discharge of acute heart failure patients from the emergency de-partment. European Heart Journal: Acute Cardiovascular Care 2017

12. Mont L, Pelliccia A, Sharma S, Biffi A, Borjesson M, Brugada Terradel-las J, Carr� F, Guasch E, Heidbuchel H, La Gerche A, Lampert R, McKenna W, Papadakis M, Priori SG, Scanavacca M, Thompson P, Sticherling C, Viskin S, Wilson M, Corrado D; Reviewers., Lip GY, Gorenek B, Blomstršm Lundqvist C, Merkely B, Hindricks G, Hern‡ndez-Madrid A, Lane D, Boria-ni G, Narasimhan C, Marquez MF, Haines D, Mackall J, Manuel Marques-Vidal P, Corra U, Halle M, Tiberi M, Niebauer J, Piepoli M. Pre-participation cardiovascular evaluation for athletic participants to prevent sudden cardi-ac death: Position paper from the EHRA and the EAPCR, branches of the ESC. Endorsed by APHRS, HRS and SOLACE. Eur J Prev Cardiol 2017. Impact Factor 3.606. Europace 2017. Impact Factor 4.530

53

Publikationen

10 Publikationen

21. Sarkozy A, De Potter T, Heidbuchel H, Ernst S, Kosiuk J, Vano E, Picano E, Arbelo E, Tedrow U, Y H Lip G, Bajers F, Blomstršm Lundqvist C, Mandrola J, Lane DA, Dagres N, Chung MK, Wunderle KA, Lip G, Gorenek B, Sticherling C, Fauchier L, Goette A, Jung W, Vos MA, Brignole M, Elsner C, Dan GA, Marin F, Boriani G, Lane D, Lundqvist CB, Savelieva I. Occupational radiation exposure in the electrophysiology laboratory with a focus on personnel with repro-ductive potential and during pregnancy: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart rhythm Society (HRS). Europace 2017. Impact Factor 4.530

22. StŠmpfli SF, Erhart L, Hagenbuch N, StŠhli BE, Gruner C, Greut-mann M, Niemann M, Kaufmann BA, Jenni R, Held L, Tanner FC. Prognostic power of NT-proBNP in left ventricular non-compaction cardiomyopathy. Int J Cardiol. 2017. Impact Factor 6.189

23. Timmermanns Y, Meine M, Zitron E, Widdershoven J, Kimman G, Prevot S, Rauwolf T, Anselme F, Szendey I, Roldan J, Mabo P, Schaer B, Denollet J, Versteeg H. The patient perspective on remote monitoring of patients with an implantable cardioverter defibrillator: Narrative review and future directions. Pacing Clin Electrophysiol 2017. Impact Factor 1.486

24. Twerenbold R, Jasper Boeddinghaus, Thomas Nestelberger, Karin Wildi, Maria Rubini Gimenez, Patrick Badertscher, Mueller C. Clinical use of high-sensitivity cardiac troponin in patients with suspected myocardial infarction. J Am Coll Cardiol. 2017. Impact Factor 19.896

25. Zellweger MJ. The complex principle of cause and effect. J Nucl Cardiol. 2017. Impact Factor 3.930

Editorials

1. Cleland JG, Mueller C. What can we learn from SOCRATES: more questions than answers? Eur Heart J. 2017. Impact Factor 19.651

2. Haaf P, Buser PT. Map to the future of cardiac magnetic reso-nance in myocarditis. Eur Heart J Cardiovasc Imaging. 2017. Im-pact Factor 5.990

3. Haaf P. Lowering the bar of high-sensitivity cardiac troponin: more than limbo dancing? J Lab Precis Med 2017.

4. KŸhne M, Knecht S, Sticherling C. Editorial: Cryoballoon ablation: the pure and simple truth about the left common ostium? Heart Rhythm 2017. Impact Factor 4.866

13. Mšckel M, Giannitsis E, Mueller C, Huber K, Jaffe AS, Mair J, Plebani M, Thygesen K, Lindahl B; Biomarker Study Group of the European Society of Cardiology Acute Cardiovascular Care Associ-ation. Rule-in of acute myocardial infarction: Focus on troponin. Eur Heart J Acute Cardiovasc Care. 2017

14. Mueller C, Giannitsis E, Mšckel M, Huber K, Mair J, Plebani M, Thygesen K, Jaffe AS, Lindahl B; Biomarker Study Group of the ESC Acute Cardiovascular Care Association. Rapid rule out of acute myocardial infarction: novel biomarker-based strategies. Eur Heart J Acute Cardiovasc Care. 2017

15. MŸller C, Mšckel M, Giannitsis E, Huber K, Plebani M, Thygesen K, Jaffe AS, Mair J, Lindahl B,; Biomarker Study Group of the Euro-pean Society of Cardiology Acute Cardiovascular Care Association. Use of copeptin for rapid rule-out of acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2017

16. MŸller C, Stefan Windecker, Marco Roffi fŸr die ESC 2015 NS-TE-ACS Task Force. Akutes Koronarsyndrom ohne ST-Hebungen: ESC-Richtlinien 2015. J CARDIOVASC MED 2017. Impact Factor 1.613

17. Price S, Platz E, Cullen L, Tavazzi G, Christ M, Cowie M, Maisel A, Masip J, Miro O, McMurray J, Peacock WF, Martin-Sanchez FJ, Di Somma S, Bueno H, Zeymer U, Mueller C. The use of echo-cardio-graphy and lung ultrasound in the assessment and manage-ment of patients with acute heart failure. Nature Reviews Cardiol 2017. Impact Factor 14.299

18. Reek S, Burri H, Roberts PR, Perings C, Epstein AE, Klein HU, Lip G, Goronek B, Sticherling C, Fauchier L, Goette A, Jung W, Vos MA, Brignole M, Elsner C, Dan GA, Marin f, Boriani G, Lane D, Lundqvist CB, Savelieva I. The wearable cardioverter-defibrillator: current technology and evolving indications. Europace 2017. Im-pact Factor 4.530

19. Roos-Hesselink JW, Tobler D, Warnes C. The 2017 Seventh World Congress of Pediatric Cardiology & Cardiac Surgery: week in review - adults with CHD. Cardiol Young. 2017. Impact Fac-tor 0.905

20. Sabti Z, Jeger R. VollstŠndig resorbierbare Stents � eine neue �ra in der Behandlung der koronaren Herzkrankheit? Praxis (Bern 1994). 2017. Impact Factor 0.06

54

5. Mueller C. Clinical utility of biomarkers in heart failure. Eur J Heart Fail. 2017. [Epub ahead of print]. Impact Factor 6.968

6. Sticherling C, KŸhne M. Editorial: Pulmonary vein isolation wi-thout assessing pulmonary vein potentials � not there yet. Heart Rhythm 2017. Impact Factor 4.866

Letters to the editor

1. Badertscher P, du Fay de Lavallaz J, Mueller C. Prevalence of pulmonary embolism among patients hospitalized for syncope. N Engl J Med 2017. Impact factor 72.406

2. Badertscher P, Kuehne M, Schaer B, Sticherling C, Osswald S, Reichlin T. Electrical storm during induced hypothermia in a pati-ent with early repolarization. BMC Cardiovasc Disord 2017. Impact Factor 1.832

3. Badertscher P, Nestelberger T, Boeddinghaus J, Twerenbold R, Wildi K, Rubini Gimenez M, Mueller C. High sensitive cardiac tro-ponin T: Testing the test. Int J Cardiol 2017. Impact Factor 6.189

4. Flores D, Sabti Z, Kozhuharov N, Mueller C. Sacubitril/valsartan in PARADIGM-HF. Lancet Diabetes Endocrinol. 2017. Impact Factor 19.742

5. KŸhne M. Vorhofflimmern 2017 � die neuen ESC-Guidelines hel-fen, aber es bleiben offene Fragen. Praxis (Bern 1994) 2017. Impact Factor 0.06

6. Mueller C, Roffi M, on behalf of the ESC NSTE-ACS Guidelines. Assessment of the European Society of Cardiology 0 hour/1hour algorithm to rule-out and rule-in acute myocardial infarction. Circu-lation 2017. Impact factor 19.309

Case reports

1. Knecht S, Spies F, Altmann D, Reichlin T, Sticherling C, KŸhne M. Electroanatomic mapping of atrial tachycardia � manual vs automa-ted annotation. HeartRhythm Case Rep. 2017. Impact Factor 4.866

2. Spies F, Knecht S, Reichlin T, KŸhne M, Sticherling C. Remotely navigated ablation of RVOT tachycardia. Cardiovasc Med 2017. Im-pact Factor 1.613

3. Zutter A, Hauri K, Evers KS, Uhde S, Fassl J, Reuthebuch OT, Berset A, KŸhne M, Donner BC. "Chaotic Arrhythmia" During Suc-cessful Resuscitation After Ingestion of Yew (Taxus baccata) Need-les. Pediatr Emerg Care. [Epub ahead of print]. Impact Factor 1.034

Books / Book chapters

1. Greutmann M, Tobler D (2017) Supportive and Palliative Care for End-Stage adult congenital heart disease in: Gatzoulis, M; Webb, G; Daubeney, P. (eds) Diagnosis and Management of Congenital Heart Disease, 3rd edition. Elsevier Verlag ISBN 9780702069291, © 2017

2. Greutmann M., Tobler D. (2017) Cyanotic lesions in: In: Roos-Hesselink J., Johnson M. (eds) Pregnancy and Congenital Heart Di-sease. Congenital Heart Disease in Adolescents and Adults. Sprin-ger, Cham. https://doi.org/10.1007/978-3-319-38913-4_16

3. Mannhardt I, Marsano A, Teuschl A. Perfusion Bioreactors for Prevascularization Strategies in Cardiac Tissue Engineering in Va-scularization for Tissue Engineering and Regenerative Medicine, Springer International Publishing, 2017 pp 1-14. doi:10.1007/978-3-319-21056-8_14-1.

4. Mueller C. Other Biomarkers and the Evaluation of Patients With Suspected Myocardial Acute Myocardial Infarction. in Morrow: Myocrdial Infarction A Companion to Braunwald's Heart Disease, 2017; 1e. Chapter 8.

5. Oechslin E, Greutmann M, Tobler D, Colman J (2017) Selec-ted Terms Used in Adult Congenital Heart Disease in: Gatzou-lis, M; Webb, G; Daubeney, P. (eds) Diagnosis and Management of Congenital Heart Disease, 3rd edition. Elsevier Verlag ISBN 9780702069291, © 2017

6. Tobler D., Greutmann M. (2017) Transpostion of the great arteries. In: Roos-Hesselink J., Johnson M. (eds) Pregnancy and Congenital Heart Disease. Congenital Heart Disease in Adolescents and Adults. Springer, Cham. https://doi.org/10.1007/978-3-319-38913-4_8

7. Tobler D., Jimenez-Juan L., Crean A.M., Wald R.M. (2017) Tri-cuspid Valve Abnormalities in: Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2017_108

55

Auszeichnungen

Auszeichnungen / Befšrderungen

PD Dr. Tobias Reichlin: Ruf als Extraordinarius fŸr Elektro- physiologie, Inselspital Bern

Prof. Christian Sticherling: Stv. Chefarzt Kardiologie

Dissertationen

Dissertationen bei Prof. David Conen

Dr. Fischer Andreas Charles: Plasma levels of endothelin-1 and renal function among young and healthy adults

Dr. Kreuzmann Rahel Ursula: Determinants of Left Atrial Volu-me in Patients with Atrial Fibrillation

Dr. Maseli Anna: Healthy Lifestyle and Blood Pressure Varia-bility in Young Adults

Dr. Muff Christoph Martin: Prospective Assessment of Sex-Related Differences in Symptom Status and Health Perception Among Patients With Atrial Fibrillation

Dr. von Rotz Mirco Lukas: Risk factors for premature ventricu-lar contractions in young and healthy adults

Dr. Zimny Matylda Magdalena: Uptake of non-vitamin K anta-gonist oral anti-coagulants in patients with atrial fibrillation � a prospective cohort study

Dissertationen bei PD Dr. Jens Fassl

Dr. Mayer Tanja Melanie: Urine Biomarkers of Tubular Renal Cell Damage for the Prediction of Acute Kidney Injury After Cardiac Surgery - A Pilot Study

11 Auszeichnungen

Dissertationen bei PD Dr. Mischa KŸhne

Dr. Fabian Burch: First clinical experience of a dedicated irri-gated-tip radiofrequency ablation catheter for the ablation of cavo

Dissertationen bei Prof. Christian MŸller

Dr. Barata Sara: Diagnostic and Prognostic Value of Cystatin C in Acute Heart Failure

Dr. Dang Minh Quy: Risk stratification by preoperative high-sensitivity troponin and NT-BNP in patients undergoing non-cardiac

Dr. Hillinger Petra: Gender-specific uncertainties in the diagno-sis of acute coronary syndrome

Dr. Hodel Karin: Diagnostic Accuracy of Cardiovascular Risk Factors for an Acute Coronary Syndrome

Dr. Lšffel Sarah: Direct comparison of cardiac myosin-binding protein C to cardiac troponins for the early diagnosis of acute myocardial infarction

Dr. Pfister Tabea Lon Ming: The Acute Cardiorenal Syndrome versus Acute Kidney Injury in Non-Cardiac Dyspnea: Long-term Mortality and Progression of Renal Disease

Dr. Radosavac Milos: New quality indicator for treatment of acute myocardial infarction

Dr. Sedlmayer Raphael Paul: Near-Linearity of Release of Car-diac Troponin in Early Acute Myocardial Infarction

Dr. Wagener Max: Diagnostic and Prognostic Value of Lead aVR During Exercise Testing in Patients Suspected of Having Myocardial Ischemia

56

Dissertationen bei PD Dr. Otmar Pfister

Dr. Fischer Marc Lorenz: Congestive heart failure with conco-mitant tachyarrhythmia: Predictors for tachycardiomyopathy

Dissertationen bei PD Dr. Anna Marsano

Dr. Mytsyk Miroslava: Paracrine potential of adipose tissue-derived stromal vascular fraction cells to recover hypoxia-induced loss of cardiomyocyte function

Forschungspreis

Dr. Federico Moccetti: Young Investigator’s Award American Society of Echocardiography 2017

57

Kontakt

Kardiologie Basel

ChefarztProf. Dr. med. Stefan Osswald

AnschriftKardiologie BaselUniversitŠtsspital BaselPetersgraben 4CH - 4031 Baselunispital-basel.ch/kardiologie

Allgemeine AuskŸnfteTel +41 61 265 44 44, Fax +41 61 265 45 98Email: kardiologie@usb.ch

Anmeldung ambulante und stationŠre Patienten Tel. +41 61 265 44 45, Fax +41 61 265 55 75Email: anmeldung.kardiologie@usb.ch

Anmeldung kardiale RehabilitationTel. +41 61 328 65 27, Fax +41 61 265 55 03Email: karamba@usb.ch

Dienstarzt KardiologieTel. + 41 61 556 58 00

12 Kontakt

Herzchirurgie Basel

ChefarztProf. Dr. med. Friedrich Eckstein

AnschriftHerzchirurgie BaselUniversitŠtsspital BaselSpitalstrasse 21CH - 4031 Baselunispital-basel.ch/herzchirurgie

ChefarztsekretariatJolanda Giess Tel. +41 61 265 71 45, Fax +41 61 265 73 24Email: jolanda.giess@usb.ch

AnmeldungStationŠre Patienten Tel. + 41 61 265 71 45Ambulante Patienten Tel. + 41 61 265 71 45Aortensprechstunde Tel. + 41 61 265 71 46

Dienstarzt HerzchirurgieTel. + 41 61 556 58 58

58

Impressum

Herausgeber: Herzzentrum Basel; Redaktion: Christoph Kaiser (Leitung), Stefan Osswald, Friedrich Eckstein, Christian MŸller, Florian RŸter, Markus Riesterer, Arton Jusaj, Ursula Vogt

Fotos: Patrick Sayer, Markus Riesterer, Fabian Fiechter, Foto & Print Center USB, Christian Jaeggi

Konzeption: Markus Riesterer; Gestaltung: strawberry design; Druck: strawberry events; Auflage: 1'500 Ex.

Diese Publikation, einschliesslich all ihrer Texte, ist urheberrechtlich geschŸtzt. Jede Verwendung ausserhalb der engen Grenzen des Urheberrechts ist ohne Zustimmung des Herzzentrums und der beteiligten Institutionen unzulŠssig und strafbar. Dies gilt insbesondere fŸr VervielfŠltigungen, †bersetzungen, Mikroverfilmungen, sowie fŸr die Einspeicherung und Verarbeitung in elektronischen Systemen.

unispital-basel.ch/kardiologie I unispital-basel.ch/herzchirurgie